<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Catal</journal-id><journal-id journal-id-type="iso-abbrev">ACS Catal</journal-id><journal-id journal-id-type="publisher-id">cs</journal-id><journal-id journal-id-type="coden">accacs</journal-id><journal-title-group><journal-title>ACS Catalysis</journal-title></journal-title-group><issn pub-type="epub">2155-5435</issn><publisher><publisher-name>American
Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5937688</article-id><article-id pub-id-type="doi">10.1021/acscatal.7b04115</article-id><article-categories><subj-group><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Engineering the &#x0201c;Missing Link&#x0201d; in Biosynthetic
(&#x02212;)-Menthol Production: Bacterial Isopulegone Isomerase</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Currin</surname><given-names>Andrew</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Dunstan</surname><given-names>Mark S.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Johannissen</surname><given-names>Linus O.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Hollywood</surname><given-names>Katherine A.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Vinaixa</surname><given-names>Maria</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Jervis</surname><given-names>Adrian J.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Swainston</surname><given-names>Neil</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath8"><name><surname>Rattray</surname><given-names>Nicholas J. W.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath9"><name><surname>Gardiner</surname><given-names>John M.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath10"><name><surname>Kell</surname><given-names>Douglas B.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath11"><name><surname>Takano</surname><given-names>Eriko</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath12"><name><surname>Toogood</surname><given-names>Helen S.</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath13"><name><surname>Scrutton</surname><given-names>Nigel S.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><aff id="aff1"><sup>&#x02020;</sup>Manchester
Centre for Fine and Speciality Chemicals (SYNBIOCHEM) and <sup>&#x02021;</sup>School of Chemistry,
Manchester Institute of Biotechnology, <institution>University
of Manchester</institution>, Manchester M1 7DN, <country>United Kingdom</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>N.S.S.: tel, <phone>+44 (0)1613065152</phone>; fax, <fax>+44 (0)1613068918</fax>; e-mail, <email>nigel.scrutton@manchester.ac.uk</email>.</corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>01</month><year>2018</year></pub-date><pub-date pub-type="ppub"><day>02</day><month>03</month><year>2018</year></pub-date><volume>8</volume><issue>3</issue><fpage>2012</fpage><lpage>2020</lpage><history><date date-type="received"><day>01</day><month>12</month><year>2017</year></date><date date-type="rev-recd"><day>15</day><month>01</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 American Chemical Society</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><license-p>This is an open access article published under a Creative Commons Attribution (CC-BY) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html">License</ext-link>, which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs-2017-04115m_0005" id="ab-tgr1"/></p><p>The
realization of a synthetic biology approach to microbial (1<italic>R</italic>,2<italic>S</italic>,5<italic>R</italic>)-(<bold>&#x02212;</bold>)-menthol (<bold>1</bold>) production relies on the identification
of a gene encoding an isopulegone isomerase (IPGI), the only enzyme
in the <italic>Mentha piperita</italic> biosynthetic
pathway as yet unidentified. We demonstrate that &#x00394;5-3-ketosteroid
isomerase (KSI) from <italic>Pseudomonas putida</italic> can act as an IPGI, producing (<italic>R</italic>)-(+)-pulegone
((<italic>R</italic>)-<bold>2</bold>) from (+)-<italic>cis</italic>-isopulegone (<bold>3</bold>). Using a robotics-driven semirational
design strategy, we identified a key KSI variant encoding four active
site mutations, which confer a 4.3-fold increase in activity over
the wild-type enzyme. This was assisted by the generation of crystal
structures of four KSI variants, combined with molecular modeling
of <bold>3</bold> binding to identify key active site residue targets.
The KSI variant was demonstrated to function efficiently within cascade
biocatalytic reactions with downstream <italic>Mentha</italic> enzymes pulegone reductase and (&#x02212;)-menthone:(&#x02212;)-menthol
reductase to generate <bold>1</bold> from <bold>3</bold>. This study
introduces the use of a recombinant IPGI, engineered to function efficiently
within a biosynthetic pathway for the production of <bold>1</bold> in microorganisms.</p></abstract><kwd-group><kwd>biosynthetic (<bold>&#x02212;</bold>)-menthol production</kwd><kwd>ketosteroid isomerase</kwd><kwd>isopulegone isomerase</kwd><kwd>enzyme
engineering</kwd><kwd>robotics</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>cs7b04115</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>cs-2017-04115m</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Limonene and its related
derivatives are the most abundant, naturally
sourced monoterpenoids known.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> These natural
products are commonly used in the perfume, fragrance, and flavor industries.<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref></sup> For example, (<italic>R</italic>)-limonene ((<italic>R</italic>)-<bold>4</bold>) is the major essential oil constituent of orange peels
and is often found in cleaning products.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> In contrast <italic>Mentha piperita</italic> (peppermint)
generates (<italic>S</italic>)-limonene ((<italic>S</italic>)-<bold>4</bold>), which is subsequently converted into menthol isomers (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>A).<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref5">5</xref></sup> The most commercially useful isomer is <bold>1</bold>, known by
its characteristic cooling anesthetic effects and aroma.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> It also has antibacterial, anticancer, and anti-inflammatory
activities, making it a valuable natural product.<sup><xref ref-type="bibr" rid="ref7">7</xref>&#x02212;<xref ref-type="bibr" rid="ref10">10</xref></sup></p><fig id="sch1" position="float"><label>Scheme 1</label><caption><title>(A) Biosynthesis
of <bold>1</bold> and (+)-Neoisomenthol (<bold>5</bold>) from (<italic>S</italic>)-<bold>4</bold> and (B) Proposed
KSI Catalytic Mechanism with <bold>3</bold>, on
the Basis of the Known Mechanism of the Enzyme towards &#x00394;5-3-Ketosteroids<sup><xref ref-type="bibr" rid="ref14">14</xref></sup></title><p id="sch1-fn1">Abbreviations: L3H = (&#x02212;)-limonene-3-hydroxylase;
IPDH = (&#x02212;)-<italic>trans</italic>-isopiperitenol dehydrogenase;
IPR = (&#x02212;)-isopiperitenone reductase; IPGI = (+)-<italic>cis</italic>-isopulegone isomerase; PGR = (+)-pulegone reductase; MMR = (&#x02212;)-menthone:(&#x02212;)-menthol
reductase; MNMR = (&#x02212;)-menthone:(&#x02212;)-neomenthol reductase.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs-2017-04115m_0003" id="gr1" position="float"/></fig><p>Commercially, <bold>1</bold> is utilized both
as a pure compound
and as a component of the essential oil of peppermint, with an estimated
30000 tons consumed annually.<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> While the
majority of <bold>1</bold> is extracted from <italic>Mentha
canadensis</italic>, a large proportion is generated synthetically
(US $300 million annually).<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> The two major
synthetic routes to <bold>1</bold> are the Haarmann&#x02013;Reimer
route from <italic>m</italic>-cresol and the Takasago synthesis utilizing
&#x003b2;-pinene.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> However, the flavor and
fragrance industries and/or consumers may demand that these compounds
be supplied from natural sources, particularly when they are used
as food additives.</p><p>Naturally sourced peppermint oil can vary
in both relative composition
of its monoterpenoid constituents and overall yields due to fluctuating
environmental conditions. This leads to price volatility and increased
arable land competition for more profitable crops, such as biofuel
biomass production. Optimization of peppermint oil production through
conventional breeding methods is difficult, as it is a sterile hybrid
plant.<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> Additionally, purification of <bold>1</bold> from essential oil requires expensive and low-yielding steam-distillation
and filtration processes to generate a usable product.<sup><xref ref-type="bibr" rid="ref16">16</xref>,<xref ref-type="bibr" rid="ref17">17</xref></sup> Therefore, alternative clean biosynthetic routes to these compounds
are a commercially attractive prospect to generate <bold>1</bold> with
a &#x0201c;natural&#x0201d; label.</p><p>One alternative &#x0201c;natural&#x0201d;
route is to introduce the
biosynthetic pathway of <bold>1</bold> into cost-effective and even
food-compatible microorganisms.<sup><xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref></sup> This general synthetic
biology approach generates biological factories, where rapid fine
chemicals production can be achieved sustainably using nonpetroleum
renewable feedstocks, with a reduced land burden and higher product
consistency and purity.<sup><xref ref-type="bibr" rid="ref20">20</xref>&#x02212;<xref ref-type="bibr" rid="ref22">22</xref></sup> Such an approach has proved commercially
successful in the semisynthetic industrial-scale production (ca. 35
tons per annum) by Sanofi of artemisinin, a major active ingredient
in modern malarial treatments. Similarly, the semisynthetic production
of Taxol has been demonstrated, where microorganism biofactories generated
the precursor taxadiene using introduced pathways.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup></p><p>We recently described the incorporation of the <italic>M.
piperita</italic> based biosynthetic pathway from (<italic>R</italic>)-<bold>2</bold> to <bold>1</bold> into <italic>Escherichia coli</italic>.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> An
in vitro protocol was established where <bold>1</bold> was successfully
generated, utilizing <italic>E. coli</italic> cell extracts
as the biocatalyst source. However, a more cost-effective route would
be an in vivo approach, where the full pathways from simple carbon
sources to <bold>1</bold> would be incorporated and the microorganisms
would be grown on waste feedstock. The six enzymatic steps from (<italic>S</italic>)-<bold>4</bold> to <bold>1</bold> in <italic>Mentha</italic> sp. have been well characterized,<sup><xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref24">24</xref>&#x02212;<xref ref-type="bibr" rid="ref30">30</xref></sup> and the native enzymes for five of these reactions have been sequenced
and functionally expressed in <italic>E. coli</italic> (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>A).<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref30">30</xref>,<xref ref-type="bibr" rid="ref31">31</xref></sup> The remaining
enzyme is isopulegone isomerase (IPGI), which catalyzes the double
bond migrating isomerization (C3&#x02013;C4 to C2&#x02013;C3) of <bold>3</bold> to (<italic>R</italic>)-<bold>2</bold> (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>B).<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> Early studies with impure native <italic>Mentha</italic> IPGI identified a 54 kDa protein complex<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref24">24</xref></sup> exhibiting
cofactor-free isomerization, utilizing a mechanism similar to bacterial
&#x00394;5-3-ketosteroid isomerases (KSI).<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> Therefore, the IPGI mechanism likely involves deprotonation of the
C2&#x003b1; hydrogen of <bold>3</bold> by an enzymatic proton acceptor
(D40 in KSI), to form an enolate intermediate (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>B), stabilized by hydrogen-bonding residues
(Y16 and D103 in KSI). A proton-donating residue then transfers its
proton to C4, leading to double bond migration to C2&#x02013;C3 and
re-formation of the carbonyl group. As no significant ketosteroid
isomerase-like proteins have been annotated in plant genomes, the
protein sequence of native IPGI is likely to remain elusive until
the completion of the full annotation of the <italic>Mentha
longifolia</italic> genome sequence.<sup><xref ref-type="bibr" rid="ref32">32</xref></sup></p><p>To complete the construction of a pathway from (<italic>S</italic>)-<bold>4</bold> to <bold>1</bold> in <italic>E. coli</italic>, we investigated a well-studied bacterial &#x00394;5-3-ketosteroid
isomerase from <italic>Pseudomonas putida</italic>(<xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref>) and found that it exhibited low
activity toward <bold>3</bold>. To improve the IPGI activity, we performed
three rounds of automated mutagenesis to improve yields of <bold>2</bold>. The crystal structures of four KSI variants were generated, to
assist the structure-guided mutagenesis approach to improve the binding
of <bold>3</bold> to the enzyme. Molecular dynamics simulations and
DFT modeling were applied to the most successful variant, to investigate
the mode of increase in activity. The performance of the optimized
KSI variant within both in vitro and in vivo biotransformation cascades
from <bold>3</bold> to <bold>1</bold> was demonstrated. Therefore,
the identification and optimization of a substitute IPGI is a critical
step in the future generation of a potentially industrial <italic>E. coli</italic> strain capable of producing &#x0201c;natural&#x0201d; <bold>1</bold>.</p></sec><sec id="sec2"><title>Experimental Section</title><sec id="sec2.1"><title>Design and Synthesis of KSI Variants</title><p>The wild-type
gene sequence encoding the &#x00394;5-3-ketosteroid isomerase from <italic>P. putida</italic> (UniProt ID: P07445) was designed using
the GeneGenie online tool, containing a C-terminal His<sub>6</sub>-tag.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> Mutagenic oligonucleotides for
the first-generation libraries encoding ambiguous codons for 16 residues
were designed optimized for <italic>E. coli</italic> expression using CodonGenie (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Tables S1 and S2</ext-link>).<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> Eight overlapping DNA oligonucleotides
(up to 80 nt in length) were used to assemble the full length genes
using the SpeedyGenes gene synthesis method (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">section S2.5</ext-link> in the Supporting Information).<sup><xref ref-type="bibr" rid="ref37">37</xref>,<xref ref-type="bibr" rid="ref38">38</xref></sup> Purified genes were ligated into linearized pET21b (Novagen) to
generate a C-terminally His<sub>6</sub>-tagged enzyme by In-Fusion
cloning (Clontech), according to the manufacturer&#x02019;s protocol.
Cloning products were transformed into T7 Express competent <italic>E. coli</italic> cells and grown on LB agar plates containing
100 &#x003bc;g/mL ampicillin, followed by incubation overnight at 37
&#x000b0;C.</p><p>The second- and third-generation variants were constructed
using asymmetric PCR mutagenesis,<sup><xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref></sup> followed by
ligation into linearized pET21b by In-Fusion cloning. These mutations
were designed as double or triple variants of the first-generation
residues identified as providing hits (V88I, L99X, and D103S). The
final variant was a combination of four individual positive mutations
(V88I/L99V/V101A/D103S).</p></sec><sec id="sec2.2"><title>Gene Synthesis of <italic>Mentha</italic> Biocatalysts</title><p>The protein sequences for the following enzymes
from <italic>M. piperita</italic> were obtained from
UniProt (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.uniprot.org">http://www.uniprot.org</uri>): pulegone
reductase (MpPGR; Q6WAU0) and (&#x02212;)-menthone:(&#x02212;)-menthol
reductase (MMR; Q5CAF4). The respective gene sequences were designed
and synthesized and subcloned into pET21b by GeneArt (ThermoFisher),
incorporating a C-terminal His<sub>6</sub>-tag and applying codon
optimization techniques of rare codon removal for optimal expression
in <italic>E. coli</italic>. Each construct was transformed
into <italic>E. coli</italic> T7 Express and grown on
LB agar plates containing 100 &#x003bc;g/mL ampicillin, followed by
incubation overnight at 37 &#x000b0;C.</p></sec><sec id="sec2.3"><title>Robotics-Driven Production
and Purification of Variant Libraries</title><p>Robotic colony picking
and auto induction media inoculation (Formedium,
100 &#x003bc;g/mL ampicillin) of first-generation libraries were performed
in deep-well plates (Hamilton Robotics), including replica plating
into LB (Formedium, 100 &#x003bc;g/mL ampicillin) for glycerol stock
generation. Plates were covered with a Breathseal sealer (Greiner
Bio-One) and incubated at 30 &#x000b0;C and 1000 rpm for 24 h. Each variant
underwent robotic cell lysis, extraction, and purification using Ni-NTA
resin (Qiagen; 50 &#x003bc;L per variant) prior to enzymatic assays
(see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">section S3.1</ext-link> in the Supporting Information
for details). Enzyme concentrations were determined using the Bradford
assay (Bio-Rad) following the manufacturer&#x02019;s protocol.</p></sec><sec id="sec2.4"><title>KSI Variant
Biotransformation Screen</title><p>Substrate <bold>3</bold> (85% purity)
was synthesized by Dr. Aisling Miller (University
of Manchester), using a combination of chemical and enzymatic transformations.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> Reactions (200 &#x003bc;L) were performed in 50
mM Tris pH 7.0 containing <bold>3</bold> (1 mM) and KSI extract (189
&#x003bc;L) and incubated at 30 &#x000b0;C for 24 h (180 rpm). Samples
were prepared for GCMS analysis by solvent extraction with 180 &#x003bc;L
of ethyl acetate containing 0.01% <italic>sec</italic>-butylbenzene
as the internal standard and dried with anhydrous MgSO<sub>4</sub>. GC-MS achiral quantitative analysis was conducted on a 7890B GC
coupled to a 5975 series MSD quadrupole mass spectrometer and equipped
with a 7693 autosampler (Agilent Technologies). Chiral product analysis
was performed by analyzing reactions by GC using an Agilent Technologies
7890A GC system with an FID detector and a Chirasil-DEX-CB column
(Agilent; 25 m, 0.32 mm, 0.25 &#x003bc;m). Further chromatography details
can be found in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">section S3.2</ext-link> in the Supporting
Information.</p><p>Yields of (<italic>R</italic>)-<bold>2</bold> were
corrected for the initial concentration present in substrate <bold>3</bold> (15%). Due to limitations in the quantity of in-house synthesized <bold>3</bold>, three colonies per plate were pooled together to test for
an increase in yield of (<italic>R</italic>)-<bold>2</bold>. Pooled
samples exhibiting an increased (<italic>R</italic>)-<bold>2</bold> yield in comparison to wild-type KSI were rescreened individually,
as above, to identify the well(s) responsible for the improved yield.
Quantification was performed by comparing the peak areas to the calibration
curves of authentic standards. Vendor binary files were converted
to open mzXML data format<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> using ProteoWizard
msConvert.<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> Automated peak profiling and
quantification was conducted using in-house scripts written in R.</p></sec><sec id="sec2.5"><title>Comparative Activity of the Variants</title><p>First-generation
KSI variant hits and later mutants generated by site-specific mutagenesis
were cultured from glycerol stocks in LB medium containing 100 &#x003bc;g/mL
ampicillin as above. The KSI-encoding plasmids were extracted and
purified (Macherey-Nagel) and underwent Sanger sequencing to identify
the mutation present. Larger scale cultures (500 mL) were generated
for each variant in the same antibiotic-selective LB medium and incubated
at 37 &#x000b0;C (180 rpm) to an OD<sub>600nm</sub> value of 0.6&#x02013;0.8,
followed by induction with 0.1 mM isopropyl-&#x003b2;-<sc>d</sc>-thiogalactopyranoside
(IPTG). Cultures were incubated overnight at 25 &#x000b0;C (180 rpm)
and the cells harvested by centrifugation (3000<italic>g</italic> for
5 min). Each variant underwent extraction (4 mL of lysis buffer) and
purification (0.5 mL Ni-NTA resin) using the same protocol and buffers
as in the initial screen (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">section S3.1</ext-link> in
the Supporting Information). Biotransformations were performed with
1 mM <bold>3</bold> as above (10 &#x003bc;M KSI), and the variants that
did not display improved yield of (<italic>R</italic>)-<bold>2</bold> above wild type (false positives) were discarded.</p></sec><sec id="sec2.6"><title>Steady-State
Reactions with (+)-<italic>cis</italic>-Isopulegone</title><p>Continuous
steady-state reactions with <bold>3</bold> were performed
with selected purified variants to investigate the effect of the mutation(s)
on the reaction rate. Reaction mixtures (100 &#x003bc;L) were composed
of 50 mM Tris pH 7.0 containing 1 mM <bold>3</bold> within UV-Star
microplates (Greiner Bio-One) and covered with a ClearVue sealing
sheet. Product formation was detected by monitoring the absorbance
at 260 nm for 1 h at 20 &#x000b0;C using a CLARIOstar microplate reader
(BMG Labtech). Concentrations were determined by comparison to a standard
curve (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Figure S1</ext-link>), and data were corrected
for both <bold>3</bold> and (<italic>R</italic>)-<bold>2</bold> loss
over 1 h (control substrate and product data).</p></sec><sec id="sec2.7"><title>Cascade Biocatalysis</title><p>The <italic>Mentha</italic> enzymes MpPGR and MMR
were produced (500 mL of culture; 20 &#x000b0;C)
and purified according to the method for the KSI variants (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">section S3.1</ext-link> in the Supporting Information).
Reactions (200 &#x003bc;L) were performed in 50 mM Tris pH 7.0 containing
10 &#x003bc;M KSI, 1 &#x003bc;M MpPGR, 0.3 &#x003bc;M MMR, 1 mM <bold>3</bold>, and a cofactor recycling system (10 U Sigma glucose dehydrogenase,
10 &#x003bc;M NADP<sup>+</sup>, and 15 mM <sc>d</sc>-glucose) to supply
MpPGR and MMR with NADPH.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> Reaction mixtures
were incubated at 30 &#x000b0;C for 24 h (180 rpm), and the extracts
were analyzed by GC-MS as before.</p></sec><sec id="sec2.8"><title>Pathway Assembly and in
Vitro Activity</title><p>The genes encoding
KSI variant V88I/L99V/V101A/D103S, MpPGR, and MMR and their respective
ribosomal binding sequences (RBS) were amplified by PCR and ligated
into pET21b using In-Fusion cloning to create an expression construct
under the control of one T7 promoter. The RBS of MMR was modified
by PCR mutagenesis to generate three constructs with lower predicted
translation initiation rates (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Table S3</ext-link>).
Each construct was transformed into competent <italic>E. coli</italic> NEB5&#x003b1; cells and underwent culture growth, plasmid purification,
and DNA sequencing as before.</p><p>The plasmids were transformed
into competent <italic>E. coli</italic> NiCo21 (DE3)
expression cells and cultured on LB agar containing 100 &#x003bc;g/mL
ampicillin. Single colonies were selected and grown in 200 mL of phosphate
buffered Terrific Broth pH 7.0 containing 0.4% glycerol and 100 &#x003bc;g/mL
ampicillin, followed by induction with 0.1 mM IPTG. The cultures were
incubated overnight at 20 &#x000b0;C and harvested by centrifugation
(3000<italic>g</italic>). Soluble cell extracts were generated using
lysis buffer (3 mL pH 7.0), sonication, and centrifugation as above.
Cascade biocatalysis reactions were set up as before, except the purified
enzymes were replaced with 50 &#x003bc;L of cell extract.</p></sec><sec id="sec2.9"><title>Protein Crystallization
and Structure Solution</title><p>Purified
KSI variants D103S, V88I/L99V, V88I/L99V/D103S and V88I/L99V/V101A/D103S
(10 mg/mL) were crystallized using a Mosquito robot (TTP Labtech)
and the following crystallization solutions: (i) 10&#x02013;25% PEG3350
with 0.2 M MgCl<sub>2</sub>, (ii) 10&#x02013;25% PEG3350 with 0.2 M
ammonium acetate (pH 4.6), and (iii) 10&#x02013;25% PEG3350 with 0.2
M ammonium acetate (pH 5.5). Crystals were flash-frozen in 30% glycerol
and data collected at the Diamond light source (beamlines IO4 and
IO3). Reflections were merged and scaled with Xia2.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> All mutant structures were solved by molecular replacement
using Phaser-MR (CCP4)<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> and wild-type
KSI (PDB code: 1OPY) as a search model. Initial model building was done with AutoBuild
(PHENIX)<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> followed by iterative cycles
of manual model building and refinement in COOT<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> and Phenix.refine,<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> respectively.
Mutations could be clearly identified in <italic>F</italic><sub>o</sub> &#x02013; <italic>F</italic><sub>c</sub> difference maps and were
modeled accordingly. The final data collection and refinement statistics
are found in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Table S4</ext-link>. The atomic coordinates
and structure factors (6F4Y, 6F50, 6F53, and 6F54) have been deposited
in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics,
Rutgers University, New Brunswick, NJ (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.rcsb.org/">http://www.rcsb.org/</uri>).</p></sec><sec id="sec2.10"><title>Molecular Modeling</title><p>DFT modeling was performed using
Gaussian09 revision D.01.<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> An active site
model was created from the crystal structure of KSI with bound androstenedione
(<bold>6</bold>; PDB ID 1OHS) including the side chains and &#x003b1;-carbons of
the 15 first-shell residues shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Figure S4</ext-link>, with substrate <bold>3</bold> built in using the coordinates of
the corresponding ligand <bold>6</bold> atoms as the starting point.
Energy minimization was carried out using the B3LYP hybrid functional
and 6-31G(d) basis sets<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> with the D3 version
of Grimme&#x02019;s dispersion.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Since
the active site is solvent exposed, a continuum solvent model was
used to mimic the shielding effect of water. Molecular dynamics simulations
were carried out using Gromacs 4.6.1 with the Gromos 53A6 force field
and periodic boundary conditions.<sup><xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref53">53</xref></sup> For WT KSI,
the crystal structure of KSI with bound <bold>6</bold> (PDB: 1OHS) was used, with
substrate <bold>3</bold> built in using the coordinates of the corresponding
ligand <bold>6</bold> atoms as the starting point. For KSI variant
V88I/L99V/V101A/D103S, ligand <bold>3</bold> was placed in the active
site of the crystal structure (PDB: 1OPY) by aligning the protein to the wild-type
KSI model. The energy minimization parameters are described in detail
in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">section S6</ext-link> in the Supporting Information.</p></sec></sec><sec id="sec3"><title>Results and Discussion</title><sec id="sec3.1"><title>Identification of KSI as a (+)-<italic>cis</italic>-Isopulegone
Isomerase</title><p>Prior studies with the partially purified native <italic>M. piperita</italic> isomerase suggested its mechanism resembled
that of the bacterial &#x00394;5-3-ketosteroid isomerase family (EC
5.3.3.1).<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> These enzymes catalyze the
isomerization of &#x00394;5-3-ketosteroids, such as 5(10)estrene-3,17-dione,
to the equivalent &#x00394;4-3-ketosteroid by intramolecular transfer
of the C4&#x003b2; proton to the C6&#x003b2; position.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> Prior studies showed that KSI from <italic>P. putida</italic> reacts with the truncated substrate 3-cyclohexen-1-one, forming
the more stable 2-cyclohexen-1-one.<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> Therefore,
we postulated that KSI might react with the structurally related compound <bold>3</bold> to generate (<italic>R</italic>)-<bold>2</bold> using a
similar mechanism (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>B).</p><p>A C-terminally His<sub>6</sub>-tagged version of
wild-type KSI from <italic>P. putida</italic> was generated,
and biotransformations with <bold>3</bold> showed that <bold>2</bold> was formed (35% yield). Chiral GC analysis confirmed that the product
generated was (<italic>R</italic>)-<bold>2</bold>, the enantiomeric
form required for <bold>1</bold> biosynthesis (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Table S5</ext-link>).<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> An additional minor
quantity (&#x0003c;1% yield) of the side product (&#x02212;)-<italic>trans</italic>-isopulegone (<bold>7</bold>) was also detected. As the (<italic>R</italic>)-<bold>2</bold> yields were judged to be too low for biotechnological
applications, we employed a directed evolution strategy to engineer
KSI for improved synthesis of (<italic>R</italic>)-<bold>2</bold>.</p></sec><sec id="sec3.2"><title>Automated Directed Evolution of KSI</title><p>Comparative studies
of KSI with single- and multiple-ring substrates showed that, while
the specificity (<italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>m</sub>) is 27000-fold higher for steroid substrates, the reaction
rates were within 2-fold.<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> This suggests
that remote binding interactions with steroid substrates have a marked
effect on the strength of substrate binding, and single-ring substrates
such as <bold>3</bold> may have poor binding affinity. Therefore,
our initial KSI mutagenesis strategy was to increase binding of <bold>3</bold> by targeting every amino acid known or predicted to interact
with steroid substrates. An examination of the cocrystal structure
of wild-type KSI bound to the reaction intermediate analogue equilenin
(PDB 1OH0)<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> showed that 16 residues were located within
5 &#x000c5; of the ligand. Given the overall apolar nature of the KSI
active site and <bold>3</bold>, maintaining this environment would
likely maximize our search for optimized mutations while minimizing
the size of the variant libraries and subsequent screening effort.
Reducing the number of screening assays was critical, given the limited
availability of the in-house-synthesized substrate <bold>3</bold>.</p><p>Twelve of these residues were targeted for individual limited randomizing
mutagenesis, where the general physicochemical properties of the amino
acids were conserved (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Table S1</ext-link>). Residues
Y16 and Y57 are both known to partake in H bonding with the substrate
carbonyl moiety; therefore, these residues were mutated combinatorially,
using an ambiguous codon (WVC) that encodes other residues capable
of H bonding. Similarly, residues V88 and L99 were selected for combinatorial
mutations using an ambiguous codon (DTK) for hydrophobic residues,
given their close proximity to the substrate analogue.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> Variant sequences were created by gene synthesis
using ambiguous codons (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Table S2</ext-link>) and constructed
using the SpeedyGenes protocols.<sup><xref ref-type="bibr" rid="ref37">37</xref>,<xref ref-type="bibr" rid="ref38">38</xref></sup> In total,
158 variants were created and screened for improvement in (<italic>R</italic>)-<bold>2</bold> production using automated robotic culturing
and protein purification protocols (summarized in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Figure S2</ext-link>). Comparative biotransformations were performed
with <bold>3</bold>, with quantitation and product identification
by GC-MS, to identify variants with activity higher than that of wild-type
KSI.</p><p>Four enzyme variants were identified as having minor increases
in (<italic>R</italic>)-<bold>2</bold> yield (1.4&#x02013;1.7 fold),
three of which contained mutations of residue L99 (L99I, L99V, and
V88I/L99V; <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).
Interestingly, both L99I and L99V involve mutations to a smaller side
chain, suggesting that these changes may affect <bold>3</bold> binding
by reducing steric hindrance. The fourth improved variant D103S also
contained a smaller side chain; however, there was also a change from
a negatively charged moiety to a polar functionality. As a serine
hydroxyl group can participate in H bonding, this mutation might maintain
the native enzyme hydrogen-bonding interaction with the substrate
carbonyl group.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Biotransformations of Wild-Type and
Variant KSI with <bold>3</bold><xref rid="t1fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="char" char="&#x000b1;"/><col align="char" char="."/></colgroup><thead><tr><th style="border:none;" align="center">round</th><th style="border:none;" align="center">variant</th><th style="border:none;" align="center" char="&#x000b1;">activity<xref rid="t1fn2" ref-type="table-fn">b</xref></th><th style="border:none;" align="center" char=".">rel activity
(fold)</th></tr></thead><tbody><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">wild type</td><td style="border:none;" align="char" char="&#x000b1;">13.88&#x000a0;&#x000b1;&#x000a0;0.08</td><td style="border:none;" align="char" char=".">1.0</td></tr><tr><td style="border:none;" align="left">1</td><td style="border:none;" align="left">D103S</td><td style="border:none;" align="char" char="&#x000b1;">20.09&#x000a0;&#x000b1;&#x000a0;1.16</td><td style="border:none;" align="char" char=".">1.4</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">L99I</td><td style="border:none;" align="char" char="&#x000b1;">23.58&#x000a0;&#x000b1;&#x000a0;0.10</td><td style="border:none;" align="char" char=".">1.7</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">L99V</td><td style="border:none;" align="char" char="&#x000b1;">18.46&#x000a0;&#x000b1;&#x000a0;0.48</td><td style="border:none;" align="char" char=".">1.3</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">V88I/L99V</td><td style="border:none;" align="char" char="&#x000b1;">19.39&#x000a0;&#x000b1;&#x000a0;0.57</td><td style="border:none;" align="char" char=".">1.4</td></tr><tr><td style="border:none;" align="left">2</td><td style="border:none;" align="left">V88I/L99V/D103S</td><td style="border:none;" align="char" char="&#x000b1;">26.47&#x000a0;&#x000b1;&#x000a0;1.59</td><td style="border:none;" align="char" char=".">1.9</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">L99V/D103S</td><td style="border:none;" align="char" char="&#x000b1;">25.51&#x000a0;&#x000b1;&#x000a0;0.83</td><td style="border:none;" align="char" char=".">1.8</td></tr><tr><td style="border:none;" align="left">&#x000a0;</td><td style="border:none;" align="left">L99I/D103S</td><td style="border:none;" align="char" char="&#x000b1;">25.91&#x000a0;&#x000b1;&#x000a0;0.58</td><td style="border:none;" align="char" char=".">1.9</td></tr><tr><td style="border:none;" align="left">3</td><td style="border:none;" align="left">V88I/L99V/V101A/D103S</td><td style="border:none;" align="char" char="&#x000b1;">63.10&#x000a0;&#x000b1;&#x000a0;0.61</td><td style="border:none;" align="char" char=".">4.5</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Duplicate reactions (200 &#x003bc;L)
were performed in 50 mM Tris pH 7.0 containing 1 mM <bold>3</bold> and 10 mM KSI. After a 24 h incubation at 30 &#x000b0;C (180 rpm),
reaction mixtures were extracted with 180 &#x003bc;L of ethyl acetate
containing 0.01% <italic>sec</italic>-butylbenzene and dried with
anhydrous MgSO<sub>4</sub>. Products were analyzed by GC-MS using
a DB-WAX column.</p></fn><fn id="t1fn2"><label>b</label><p>Activity
is expressed as &#x003bc;M
(<italic>R</italic>)-<bold>2</bold> produced per &#x003bc;M KSI in 24
h.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec3.3"><title>Second Round: Compiling
Mutations</title><p>To investigate the
combinatorial effect of the initial screen variants, the L99X-containing
single and double mutants were each combined with D103S using asymmetric
PCR mutagenesis.<sup><xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref></sup> Each variant was purified and
underwent biotransformations to determine any improvement in (<italic>R</italic>)-<bold>2</bold> yield by GC-MS (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Unfortunately, these double and triple
variants showed only moderate improvements in (<italic>R</italic>)-<bold>2</bold> yield in comparison to wild-type enzyme (1.8&#x02013;1.9-fold).</p></sec><sec id="sec3.4"><title>Third Round: Structure-Guided Mutation</title><p>To ensure the
mutations in the active site and surrounding residues did not affect
the overall fold of KSI, we solved the X-ray crystal structures of
the four key variants D103S, V88I/L99V, V88I/L99V/D103S, and V88I/L99V/V101A/D103S
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Table S4</ext-link>). Each of these structures showed
backbone conformations virtually identical with the cocrystal structure
of wild-type KSI bound to the reaction intermediate analogue equilenin
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Figure S3</ext-link>),<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> with RMSD values of 0.427, 0.418, 0.443, and 0.357, respectively.
All of the mutations could be clearly identified in <italic>F</italic><sub>o</sub> &#x02013; <italic>F</italic><sub>c</sub> difference maps
and were incorporated without any major displacement of the backbone
atoms or surrounding residues. We did note minor rearrangements of
backbone atoms within the loop region 90&#x02013;98 (results not shown).
This loop is exposed to the bulk solvent and shows above average <italic>B</italic> factors in comparison to surrounding residues, implying
the observed differences are due to inherent flexibility, rather than
any mutational changes to neighboring residues.</p><p>Inspecting the
spatial arrangement of these mutations showed that residue V101 was
positioned directly between L99V and D103S, highlighting it as another
potential target for mutagenesis (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B, inset). Given that most of the existing
variants resulted in a shortening of the amino acid side chain, the
triple variant was modified to incorporate the mutation V101A. Biotransformations
were performed on the KSI V88I/L99V/V101A/D103S variant, which showed
a more dramatic increase in (<italic>R</italic>)-<bold>2</bold> production
over wild-type enzyme (4.5-fold; <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). Therefore, the modification of V101 to an alanine
residue has resulted in over a 2-fold increase in (<italic>R</italic>)-<bold>2</bold> formation over the triple variant.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Location of key active
site mutations implicated in improving KSI
activity toward <bold>3</bold>. (A) Residues located in the equilenin-binding
region of wild type KSI from <italic>P. putida</italic> (PDB: 1OH0).<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> The residues and equilenin are shown
as atom colored sticks with yellow and green carbons, respectively.
Interactions are shown as red dotted lines. The backbone is shown
as a gray cartoon. (B) Comparative steady-state activity of wild-type
and variant KSI enzymes. Reaction mixtures (100 &#x003bc;L) were composed
of 50 mM Tris pH 7.0 containing 1 mM <bold>3</bold>. The absorbance
was monitored at 260 nm for 1 h at 20 &#x000b0;C. Inset: location of
the variant residues in KSI V881/L99V/D103S. The backbone and mutations
are shown as gray ribbons and balls, respectively (blue balls for
V101).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs-2017-04115m_0001" id="gr3" position="float"/></fig><p>To investigate the effect of the
mutations further, the specific
activity of the variants with substrate <bold>3</bold> was determined
under pseudo-steady-state conditions (1 h reactions). This method
takes advantage of the enolization of <bold>3</bold> to (<italic>R</italic>)-<bold>2</bold>, which results in the development of a peak around
260 nm (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Figure S1</ext-link>). First-generation variants
showed minor rate increases (around 1.3-fold), while a near 2-fold
improvement was seen with the triple variant V88I/L99V/D103S (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B). The addition
of mutation V101A generated a 4.3-fold increase in specific activity
in comparison to the WT (61.17 &#x003bc;mol/(min mg) in comparison to
14.16 &#x003bc;mol/(min mg); <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B). Therefore, the increases in the overall reaction
rate mirror the increased product yields detected in the 24 h biotransformations.</p></sec><sec id="sec3.5"><title>Modeling and Molecular Dynamics Simulations for KSI Variants</title><p>We performed comparative DFT modeling and MD simulations between
wild-type KSI and variant V88I/L99V/V101A/D103S to investigate the
origin(s) of activity rate changes. The DFT optimized model for wild
type KSI suggests that the substrate <bold>3</bold> carbonyl group
hydrogen bonds with D103 (&#x0003c;2.0 &#x000c5;), but the orientation is
nonideal for catalysis due to a less favorable interaction distance
for the proton abstraction step (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Figure S4</ext-link>, and <xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>B). Additionally,
residue L99 has reoriented outward from the active site, causing a
twist in the &#x003b2;-hairpin from residue 88 to 99 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Figure S2</ext-link>).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Overlay of energy-minimized structure (green) and representative
structure from MD simulations (brown) for (A) wild-type KSI and (B)
variant V88I/L99V/V101A/D103S modeled with <bold>3</bold> in the active
site. The solvent-accessible surface areas for the substrate and residues
88, 99, and 101 from the representative and minimized structures,
respectively, are shown as transparent surfaces. The dotted lines
illustrate potential steric clashes between the substrate and enzyme.
The MD simulations were performed using Gaussian09 revision D.01.<sup><xref ref-type="bibr" rid="ref49">49</xref></sup></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs-2017-04115m_0002" id="gr4" position="float"/></fig><p>MD simulations of variant KSI with <bold>3</bold> restrained
in
a reactive conformation suggests that the decrease in bulk of variant
residues I88, V99, and A101 allows the substrate to comfortably adopt
this position (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B). The position of <bold>3</bold> looks more ideal, with a D40&#x02013;substrate
hydrogen&#x02013;oxygen distance of 2.04 &#x000c5; in the DFT model. Therefore,
the decrease in bulk of variant residues I88, V99, and A101 has allowed
this reorienting of the substrate, while still maintaining a (slightly
longer) hydrogen-bonding interaction with residue S103 (D103 in wild
type). MD simulations with the variant model showed no repositioning
of the hairpin loop from 88 to 99 was necessary, as <bold>3</bold> fit more easily within the active site. Overall, molecular simulations
suggest that these four mutations have improved binding of <bold>3</bold> in a functional conformation within the active site. Therefore,
the V88I/L99V/V101A/D103S variant was selected for further studies
to see if it can be used in cascade reactions for the biosynthetic
production of <bold>1</bold> from <bold>3</bold>.</p></sec><sec id="sec3.6"><title>One-pot (&#x02212;)-Menthol
Production with Purified Enzymes</title><p>Initial cascade reactions
were performed with purified enzymes
to eliminate any interference from competing <italic>E. coli</italic> enzymes present in whole cells and cell extracts (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). Interestingly, reactions
with KSI variant V88I/L99V/V101A/D103S showed the formation of &#x0223c;10%
byproducts, such as <italic>trans</italic>-isopulegone (<bold>7</bold>). This suggests that the presence of the four mutations has altered
the range of possible binding conformations of <bold>3</bold>, leading
to additional isomer formation. The pathway from <bold>3</bold> to <bold>1</bold> also requires the presence of two <italic>Mentha</italic> enzymes, namely pulegone reductase (MpPGR)<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> and (&#x02212;)-menthone:(&#x02212;)-menthol reductase (MMR), to generate
(&#x02212;)-menthone (<bold>8</bold>) and <bold>1</bold>, respectively
(<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>A).<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> Initial biocatalytic reactions of purified MpPGR
with (<italic>R</italic>)-<bold>2</bold> showed it produced near-equivalent
yields of <bold>8</bold> and (+)-isomenthone (<bold>9</bold>) (ratio
49:51; <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). This
differs slightly from previous studies of a non-His<sub>6</sub>-tagged
recombinant form of MpPGR, which showed an <bold>8</bold>:<bold>9</bold> ratio of 55:45.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> However, this enzyme
showed a significantly higher yield of <bold>8</bold> than had been
seen with the homologous enzyme from <italic>Nicotiana tabacum</italic> (NtDBR) performed under the same reaction conditions.<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> Similarly, purified MMR-His<sub>6</sub> demonstrated
activity toward <bold>8</bold> similar to that in previous studies,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> showing primarily <bold>1</bold> production (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>).</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Biotransformations of Individual Enzymes
and Cascading Reactions with <italic>Mentha</italic> Monoterpenoids<xref rid="t2fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th colspan="6" align="center">substrate
remaining/product yield (&#x003bc;M)<hr/></th></tr><tr><th style="border:none;" align="center">biocatalyst</th><th style="border:none;" align="center"><bold>3</bold></th><th style="border:none;" align="center">(<italic>R</italic>)-<bold>2</bold></th><th style="border:none;" align="center"><bold>8</bold></th><th style="border:none;" align="center"><bold>9</bold></th><th style="border:none;" align="center"><bold>3</bold></th><th style="border:none;" align="center"><bold>5</bold></th></tr></thead><tbody><tr><td colspan="7" style="border:none;" align="center">Individual Enzymes</td></tr><tr><td style="border:none;" align="left">KSI WT</td><td style="border:none;" align="left"><bold>361.7</bold> &#x000b1;
11.5</td><td style="border:none;" align="left">210.4&#x000a0;&#x000b1;&#x000a0;6.0</td><td style="border:none;" align="left">N/A</td><td style="border:none;" align="left">N/A</td><td style="border:none;" align="left">N/A</td><td style="border:none;" align="left">N/A</td></tr><tr><td style="border:none;" align="left">KSI variant<xref rid="t2fn2" ref-type="table-fn">b</xref><sup>,</sup><xref rid="t2fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left"><bold>40.7</bold> &#x000b1;
0.7</td><td style="border:none;" align="left">436.3&#x000a0;&#x000b1;&#x000a0;10.8</td><td style="border:none;" align="left">N/A</td><td style="border:none;" align="left">N/A</td><td style="border:none;" align="left">N/A</td><td style="border:none;" align="left">N/A</td></tr><tr><td style="border:none;" align="left">MpPGR</td><td style="border:none;" align="left">N/A</td><td style="border:none;" align="left"><bold>10.0</bold> &#x000b1;
1.1</td><td style="border:none;" align="left">153.3&#x000a0;&#x000b1;&#x000a0;5.8</td><td style="border:none;" align="left">160.1&#x000a0;&#x000b1;&#x000a0;4.5</td><td style="border:none;" align="left">N/A</td><td style="border:none;" align="left">N/A</td></tr><tr><td style="border:none;" align="left">MMR</td><td style="border:none;" align="left">N/A</td><td style="border:none;" align="left">N/A</td><td style="border:none;" align="left"><bold>8.0</bold> &#x000b1;
2.0</td><td style="border:none;" align="left">N/A</td><td style="border:none;" align="left">280.7&#x000a0;&#x000b1;&#x000a0;10.3</td><td style="border:none;" align="left">N/A</td></tr><tr><td colspan="7" style="border:none;" align="center">Cascading Reactions</td></tr><tr><td style="border:none;" align="left">cascade<xref rid="t2fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left"><bold>16.7</bold> &#x000b1;
1.2</td><td style="border:none;" align="left">10.3&#x000a0;&#x000b1;&#x000a0;0.1</td><td style="border:none;" align="left">25.2&#x000a0;&#x000b1;&#x000a0;0.9</td><td style="border:none;" align="left">16.6&#x000a0;&#x000b1;&#x000a0;0.5</td><td style="border:none;" align="left">63.4&#x000a0;&#x000b1;&#x000a0;3.8</td><td style="border:none;" align="left">11.1&#x000a0;&#x000b1;&#x000a0;0.6</td></tr><tr><td style="border:none;" align="left">cell extract<xref rid="t2fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left"><bold>17.1</bold> &#x000b1;
0.1</td><td style="border:none;" align="left">11.5&#x000a0;&#x000b1;&#x000a0;0.5</td><td style="border:none;" align="left">60.6&#x000a0;&#x000b1;&#x000a0;1.9</td><td style="border:none;" align="left">34.8&#x000a0;&#x000b1;&#x000a0;0.3</td><td style="border:none;" align="left">52.8&#x000a0;&#x000b1;&#x000a0;0.9</td><td style="border:none;" align="left">18.6&#x000a0;&#x000b1;&#x000a0;0.8</td></tr><tr><td style="border:none;" align="left">whole cells<xref rid="t2fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left"><bold>32.5</bold> &#x000b1;
6.7</td><td style="border:none;" align="left">1.0&#x000a0;&#x000b1;&#x000a0;2.1</td><td style="border:none;" align="left">44.7&#x000a0;&#x000b1;&#x000a0;10.3</td><td style="border:none;" align="left">98.6&#x000a0;&#x000b1;&#x000a0;2.4</td><td style="border:none;" align="left">158.8&#x000a0;&#x000b1;&#x000a0;0.4</td><td style="border:none;" align="left">19.6&#x000a0;&#x000b1;&#x000a0;0.1</td></tr></tbody></table><table-wrap-foot><fn id="t2fn1"><label>a</label><p>Duplicate reactions
(200 &#x003bc;L)
were performed in 50 mM Tris pH 7.0 containing 1 mM monoterpenoid
substrate, enzyme(s), and cofactor recycling system (10 U Sigma glucose
dehydrogenase, 10 &#x003bc;M NADP<sup>+</sup>, and 15 mM <sc>d</sc>-glucose).
After a 24 h incubation at 30 &#x000b0;C (180 rpm), reaction mixtures
were extracted with 180 &#x003bc;L of ethyl acetate containing 0.01% <italic>sec</italic>-butylbenzene and dried with anhydrous MgSO<sub>4</sub>. Products were analyzed by GC-MS using a DB-WAX column (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Figure S7</ext-link>). Reaction mixtures with individual
enzymes had enzyme concentrations of 10 &#x003bc;M. The in vitro cascading
reaction had enzyme concentrations of 10, 2, and 0.3 &#x003bc;M for
KSI variant, MpPGR, and MMR, respectively. Control biotransformations
of each compound in the absence of enzymes (data not shown) showed
losses occurred over 24 h due to nonenzymatic degradation. Therefore,
the product yields are likely an underestimation of the true yields.
The cell extract and whole cell slurry volumes in the cascading reactions
were 50 &#x003bc;L. Substrates are shown in boldface. N/A = not applicable.</p></fn><fn id="t2fn2"><label>b</label><p>KSI variant = V88I/L99V/V101A/D103S.</p></fn><fn id="t2fn3"><label>c</label><p>Additional products were detected
that were not quantified (e.g., <bold>7</bold> and (+)-neoiso-isopulegol
(<bold>10</bold>)).</p></fn></table-wrap-foot></table-wrap><p>Initial
cascade biocatalytic reactions of purified KSI wild-type
and variant V88I/L99V/V101A/D103S with MpPGR and MMR with <bold>3</bold> showed that the major product was an isomer of isopulegol (results
not shown). Chiral GC analysis of the reaction mixture showed that
the main isomer formed was (+)-neoiso-isopulegol (<bold>10</bold>),
with a minor proportion of (&#x02212;)-isopulegol generated (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Figure S6</ext-link>).<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> However,
product <bold>1</bold> was also detected, with 5.1-fold higher yields
obtained for reactions containing V88I/L99V/V101A/D103S variant KSI
(46 &#x003bc;M vs 9 &#x003bc;M).</p><p>Subsequent reactions with each
individually purified biocatalyst
showed that this side product was obtained by the action of MMR on <bold>3</bold>, which differs from earlier studies.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> However, this apparent disparity is likely due to the 144-fold reduction
in the reaction time of the earlier study in comparison to this work
(6&#x02013;9 min vs 24 h).<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> It is likely
that the mechanism of action of MMR with <bold>3</bold> proceeds in
a manner similar to that for the short chain dehydrogenase/reductase
(SDR) ketoreduction mechanism described previously for MMR and MNMR
with substrates <bold>8</bold> and <bold>9</bold> (<xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref>).<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> Unfortunately, the formation of <bold>10</bold> by MMR appeared
to dominate over the reaction with <bold>8</bold>, likely due to the
lack of the latter substrate at the start of the reaction.</p><fig id="sch2" position="float"><label>Scheme 2</label><caption><title>Proposed
Mechanism of Action of the NADPH-Dependent MMR-Catalyzed
Reduction of <bold>3</bold> to <bold>10</bold></title><p id="sch2-fn1">This is adapted from the proposed
SDR ketoreductase mechanism of MNMR with <bold>8</bold>.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs-2017-04115m_0004" id="gr2" position="float"/></fig><p>Subsequent cascade reactions
were performed with a 30-fold molar
excess of KSI over MMR, to allow KSI activity with <bold>3</bold> to
predominate. Using this approach, we dramatically increased <bold>1</bold> titers (63.4 &#x003bc;M; 14.1% conversion; <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>) relative to <bold>10</bold>, producing a near 1:1 ratio of products. In addition, a surprising
yet advantageous observation was that relatively lower levels of <bold>9</bold> (and subsequently <bold>5</bold>) than expected were produced
for MMR, with a combined ratio of 76:24 ((<bold>8</bold> + <bold>1</bold>):(<bold>9</bold> + <bold>5</bold>)). Therefore, these studies have
demonstrated that KSI variant V88I/L99V/V101A/D103S can be utilized
in cascade reactions as the first step in generating <bold>1</bold> from <bold>3</bold>.</p></sec><sec id="sec3.7"><title>Cascading Production of <bold>3</bold> Using
Cell-Free Extracts
and Whole Cells</title><p>We have previously reported the biosynthesis
of menthol isomers from (<italic>R</italic>)-<bold>2</bold>, using <italic>E. coli</italic> cell extracts expressing the enzymes NtDBR
and MMR.<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> To further extend this approach,
we developed a single expression construct in pET21b containing KSI
variant V88I/L99V/V101A/D103S, MpPGR, and MMR, with each gene under
the control of one T7 promoter (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Table S3</ext-link>). This enabled the IPTG-dependent coexpression of all three genes
in <italic>E. coli</italic>. Biotransformations were
performed using cell extracts with <bold>3</bold> in the presence
of a cofactor recycling system, the latter to supply MpPGR and MMR
with NADPH. As expected, the major product obtained was <bold>10</bold>, due to the promiscuous activity of MMR (results not shown).</p><p>To mimic the effect of increasing the KSI:MMR concentration ratio <italic>in vivo</italic>, we modified the RBS sequence upstream of MMR to
three alternative ones, each with predicted translation initiation
rates (TIR) less than the existing rate of 4100 (1000, 500, and 200; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">Table S3</ext-link>).<sup><xref ref-type="bibr" rid="ref59">59</xref>,<xref ref-type="bibr" rid="ref60">60</xref></sup> Of the three constructs,
only that containing an RBS with a predicted TIR of 500 showed any
MMR activity, leading to the production of both <bold>1</bold> and <bold>10</bold> (<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>). Cell extracts of this construct yielded 53 &#x003bc;M of <bold>1</bold>, similar to that obtained with the purified enzyme one-pot biocatalytic
reactions. The higher levels of <bold>8</bold> and <bold>9</bold> detected
reflects the lower in vivo concentration of MMR within this construct.
Reactions were also conducted with whole cells, producing nearly 3-fold
higher levels of <bold>1</bold> in comparison to cell extract biotransformations
(159 &#x003bc;M, 27% total yield; <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>) with proportionally less <bold>10</bold>.</p><p>These
studies have demonstrated that these three enzymes have great
potential in an overall strategy for in vivo production of <bold>1</bold> in <italic>E. coli</italic>. Ideally KSI V88I/L99V/V101A/D103S
would be incorporated into an <italic>E. coli</italic> construct containing all the remaining enzymes required for <bold>1</bold> production from (<italic>S</italic>)-<bold>4</bold> (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>A). This would enable
one-pot biotransformations or in vivo fermentations to be performed
using the inexpensive and renewable starting material (<italic>S</italic>)-<bold>4</bold>. Ultimately, the inclusion of an (<italic>S</italic>)-<bold>4</bold> production pathway would enable <italic>E.
coli</italic> to produce <bold>1</bold> in vivo from simple
sugars.<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> This would avoid the addition
of high concentrations of toxic monoterpenoid precursors and eliminate
the need for exogenous cofactor recycling systems. Additionally, the
low in vivo concentration of <bold>3</bold> would likely minimize
pathway hijacking to form <bold>10</bold>, increasing the overall
yields of <bold>1</bold>.</p></sec></sec><sec id="sec4"><title>Concluding Remarks</title><p>The implementation of a synthetic biology approach to microbial <bold>1</bold> production has been hampered by the absence of the sequence
for the native <italic>Mentha</italic> pathway enzyme
IPGI and the lack of identification of plant proteins exhibiting homology
to bacterial &#x00394;5-3-ketosteroid isomerases known to catalyze this
reaction on steroid substrates. We took the approach of engineering
an existing bacterial &#x00394;5-3-ketosteroid isomerase to improve
its activity toward <bold>3</bold>, using a structure-modeling-guided,
semirational design to identify target residues. Our implementation
of a robotics platform to ensure rapid and reproducible automated
gene assembly, enzyme purification, and microscale biotransformation
screening enabled the identification of potential variant biocatalysts
with limited substrate availability. The incorporation of four targeted
mutations into KSI enabled a 4.3-fold increase in IPGI activity, generating
a biotechnologically useful enzyme with significant in vivo activity.
Further engineering studies could potentially improve its functionality,
thereby driving the cascade reactions toward more efficient <bold>1</bold> production.</p><p>This is the first report of a non-<italic>Mentha</italic> enzyme with IPGI activity, thereby identifying
the &#x0201c;missing
link&#x0201d; to complete the enzymatic route from (<italic>S</italic>)-<bold>4</bold> to <bold>1</bold>. This will enable for the first
time the full construction of a biosynthetic pathway for microbial
production of <bold>1</bold>. The demonstration of successful <bold>1</bold> production from <bold>3</bold> by engineered <italic>E. coli</italic> adds to a growing number of studies highlighting
the potential usefulness of microbial hosts in monoterpenoid production.
It is anticipated that integrating our existing KSI-MpPGR-MMR construct
into a larger chassis will enable the production of menthol isomers
from inexpensive precursors, providing a sustainable and renewable
production platform to meet the growing global demand for natural
menthol products.</p></sec></body><back><notes id="notes-1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information
is available free of charge on the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org">ACS Publications website</ext-link> at DOI: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/abs/10.1021/acscatal.7b04115">10.1021/acscatal.7b04115</ext-link>.<list id="silist" list-type="simple"><list-item><p>Additional experimental
details, materials used, additional
tables and figures, results, GC/MS analyses, and discussion of computational
and crystallographic studies (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acscatal.7b04115/suppl_file/cs7b04115_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cs7b04115_si_001.pdf"><caption><p>cs7b04115_si_001.pdf</p></caption></media></supplementary-material></sec><notes id="notes-4" notes-type="COI-statement"><p>The authors
declare the following competing financial interest(s): A.C., H.S.T.,
and N.S.S. are named inventors on a submitted patent describing the
work in this paper.</p></notes><ack><title>Acknowledgments</title><p>We thank Colin Levy for protein
crystallization and data collection
and the wider SYNBIOCHEM team for their contributions. The authors
acknowledge the assistance given by IT Services and the use of the
Computational Shared Facility at The University of Manchester. The
UK Catalysis Hub (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ukcatalysishub.co.uk">http://www.ukcatalysishub.co.uk</uri>) is kindly thanked for resources and support. Funding was provided
by the Biotechnology and Biological Sciences Research Council (BBSRC)
and Engineering and Physical Sciences Research Council (EPSRC) under
grants BB/J015512/1 and BB/M017702/1.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Duetz</surname><given-names>W. A.</given-names></name>; <name><surname>Bouwmeester</surname><given-names>H.</given-names></name>; <name><surname>van Beilen</surname><given-names>J. B.</given-names></name>; <name><surname>Witholt</surname><given-names>B.</given-names></name>
<source>Appl. Microbiol. Biotechnol.</source>
<year>2003</year>, <volume>61</volume>, <fpage>269</fpage>&#x02013;<lpage>277</lpage><pub-id pub-id-type="doi">10.1007/s00253-003-1221-y</pub-id>.<pub-id pub-id-type="pmid">12743755</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Croteau</surname><given-names>R. B.</given-names></name>; <name><surname>Davis</surname><given-names>E. M.</given-names></name>; <name><surname>Ringer</surname><given-names>K. L.</given-names></name>; <name><surname>Wildung</surname><given-names>M. R.</given-names></name>
<source>Naturwissenschaften</source>
<year>2005</year>, <volume>92</volume>, <fpage>562</fpage>&#x02013;<lpage>577</lpage><pub-id pub-id-type="doi">10.1007/s00114-005-0055-0</pub-id>.<pub-id pub-id-type="pmid">16292524</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Leavell</surname><given-names>M. D.</given-names></name>; <name><surname>McPhee</surname><given-names>D. J.</given-names></name>; <name><surname>Paddon</surname><given-names>C. J.</given-names></name>
<source>Curr. Opin. Biotechnol.</source>
<year>2016</year>, <volume>37</volume>, <fpage>114</fpage>&#x02013;<lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2015.10.007</pub-id>.<pub-id pub-id-type="pmid">26723008</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Alonso-Gutierrez</surname><given-names>J.</given-names></name>; <name><surname>Chan</surname><given-names>R.</given-names></name>; <name><surname>Batth</surname><given-names>T. S.</given-names></name>; <name><surname>Adams</surname><given-names>P. D.</given-names></name>; <name><surname>Keasling</surname><given-names>J. D.</given-names></name>; <name><surname>Petzold</surname><given-names>C. J.</given-names></name>; <name><surname>Lee</surname><given-names>T. S.</given-names></name>
<source>Metab. Eng.</source>
<year>2013</year>, <volume>19</volume>, <fpage>33</fpage>&#x02013;<lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2013.05.004</pub-id>.<pub-id pub-id-type="pmid">23727191</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Davis</surname><given-names>E. M.</given-names></name>; <name><surname>Ringer</surname><given-names>K. L.</given-names></name>; <name><surname>McConkey</surname><given-names>M. E.</given-names></name>; <name><surname>Croteau</surname><given-names>R.</given-names></name>
<source>Plant Physiol.</source>
<year>2005</year>, <volume>137</volume>, <fpage>873</fpage>&#x02013;<lpage>881</lpage><pub-id pub-id-type="doi">10.1104/pp.104.053306</pub-id>.<pub-id pub-id-type="pmid">15728344</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Watt</surname><given-names>E. E.</given-names></name>; <name><surname>Betts</surname><given-names>B. A.</given-names></name>; <name><surname>Kotey</surname><given-names>F. O.</given-names></name>; <name><surname>Humbert</surname><given-names>D. J.</given-names></name>; <name><surname>Griffith</surname><given-names>T. N.</given-names></name>; <name><surname>Kelly</surname><given-names>E. W.</given-names></name>; <name><surname>Veneskey</surname><given-names>K. C.</given-names></name>; <name><surname>Gill</surname><given-names>N.</given-names></name>; <name><surname>Rowan</surname><given-names>K. C.</given-names></name>; <name><surname>Jenkins</surname><given-names>A.</given-names></name>; <name><surname>Hall</surname><given-names>A. C.</given-names></name>
<source>Eur. J. Pharmacol.</source>
<year>2008</year>, <volume>590</volume>, <fpage>120</fpage>&#x02013;<lpage>126</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2008.06.003</pub-id>.<pub-id pub-id-type="pmid">18593637</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Freires</surname><given-names>I. A.</given-names></name>; <name><surname>Denny</surname><given-names>C.</given-names></name>; <name><surname>Benso</surname><given-names>B.</given-names></name>; <name><surname>de Alencar</surname><given-names>S. M.</given-names></name>; <name><surname>Rosalen</surname><given-names>P. L.</given-names></name>
<source>Molecules</source>
<year>2015</year>, <volume>20</volume>, <fpage>7329</fpage>&#x02013;<lpage>7358</lpage><pub-id pub-id-type="doi">10.3390/molecules20047329</pub-id>.<pub-id pub-id-type="pmid">25911964</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Juergens</surname><given-names>U. R.</given-names></name>; <name><surname>St&#x000f6;ber</surname><given-names>M.</given-names></name>; <name><surname>Vetter</surname><given-names>H.</given-names></name>
<source>Eur. J. Med. Res.</source>
<year>1998</year>, <volume>3</volume>, <fpage>539</fpage>&#x02013;<lpage>545</lpage>.<pub-id pub-id-type="pmid">9889172</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Kim</surname><given-names>S.-H.</given-names></name>; <name><surname>Lee</surname><given-names>S.</given-names></name>; <name><surname>Piccolo</surname><given-names>S. R.</given-names></name>; <name><surname>Allen-Brady</surname><given-names>K.</given-names></name>; <name><surname>Park</surname><given-names>E.-J.</given-names></name>; <name><surname>Chun</surname><given-names>J. N.</given-names></name>; <name><surname>Kim</surname><given-names>T. W.</given-names></name>; <name><surname>Cho</surname><given-names>N.-H.</given-names></name>; <name><surname>Kim</surname><given-names>I.-G.</given-names></name>; <name><surname>So</surname><given-names>I.</given-names></name>; <name><surname>Jeon</surname><given-names>J.-H.</given-names></name>
<source>Biochem. Biophys. Res. Commun.</source>
<year>2012</year>, <volume>422</volume>, <fpage>436</fpage>&#x02013;<lpage>441</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2012.05.010</pub-id>.<pub-id pub-id-type="pmid">22580005</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Li</surname><given-names>Q.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Yang</surname><given-names>Z.</given-names></name>; <name><surname>Wang</surname><given-names>B.</given-names></name>; <name><surname>Li</surname><given-names>S.</given-names></name>
<source>Oncology</source>
<year>2009</year>, <volume>77</volume>, <fpage>335</fpage>&#x02013;<lpage>341</lpage><pub-id pub-id-type="doi">10.1159/000264627</pub-id>.<pub-id pub-id-type="pmid">19955836</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Kamatou</surname><given-names>G. P. P.</given-names></name>; <name><surname>Vermaak</surname><given-names>I.</given-names></name>; <name><surname>Viljoen</surname><given-names>A. M.</given-names></name>; <name><surname>Lawrence</surname><given-names>B. M.</given-names></name>
<source>Phytochemistry</source>
<year>2013</year>, <volume>96</volume>, <fpage>15</fpage>&#x02013;<lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2013.08.005</pub-id>.<pub-id pub-id-type="pmid">24054028</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Croteau</surname><given-names>R. B.</given-names></name>; <name><surname>Davis</surname><given-names>E. M.</given-names></name>; <name><surname>Ringer</surname><given-names>K. L.</given-names></name>; <name><surname>Wildung</surname><given-names>M. R.</given-names></name>
<source>Naturwissenschaften</source>
<year>2005</year>, <volume>92</volume>, <fpage>562</fpage>&#x02013;<lpage>577</lpage><pub-id pub-id-type="doi">10.1007/s00114-005-0055-0</pub-id>.<pub-id pub-id-type="pmid">16292524</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="book" id="cit13"><person-group person-group-type="allauthors"><name><surname>Sell</surname><given-names>C.</given-names></name></person-group><source>A fragrant introduction
to terpenoid chemistry</source>; <publisher-name>Royal Society of
Chemistry</publisher-name>: <publisher-loc>Cambridge, UK</publisher-loc>, <year>2003</year>; pp <fpage>43</fpage>&#x02013;<lpage>64</lpage>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Pollack</surname><given-names>R. M.</given-names></name>
<source>Bioorg. Chem.</source>
<year>2004</year>, <volume>32</volume>, <fpage>341</fpage>&#x02013;<lpage>353</lpage><pub-id pub-id-type="doi">10.1016/j.bioorg.2004.06.005</pub-id>.<pub-id pub-id-type="pmid">15381400</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Lange</surname><given-names>B. M.</given-names></name>; <name><surname>Mahmoud</surname><given-names>S. S.</given-names></name>; <name><surname>Wildung</surname><given-names>M. R.</given-names></name>; <name><surname>Turner</surname><given-names>G. W.</given-names></name>; <name><surname>Davis</surname><given-names>E. M.</given-names></name>; <name><surname>Lange</surname><given-names>I.</given-names></name>; <name><surname>Baker</surname><given-names>R. C.</given-names></name>; <name><surname>Boydston</surname><given-names>R. A.</given-names></name>; <name><surname>Croteau</surname><given-names>R. B.</given-names></name>
<source>Proc. Natl. Acad.
Sci. U. S. A.</source>
<year>2011</year>, <volume>108</volume>, <fpage>16944</fpage>&#x02013;<lpage>16949</lpage><pub-id pub-id-type="doi">10.1073/pnas.1111558108</pub-id>.<pub-id pub-id-type="pmid">21963983</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Lange</surname><given-names>B. M.</given-names></name>; <name><surname>Mahmoud</surname><given-names>S. S.</given-names></name>; <name><surname>Wildung</surname><given-names>M. R.</given-names></name>; <name><surname>Turner</surname><given-names>G. W.</given-names></name>; <name><surname>Davis</surname><given-names>E. M.</given-names></name>; <name><surname>Lange</surname><given-names>I.</given-names></name>; <name><surname>Baker</surname><given-names>R. C.</given-names></name>; <name><surname>Boydston</surname><given-names>R. A.</given-names></name>; <name><surname>Croteau</surname><given-names>R. B.</given-names></name>
<source>Proc. Natl. Acad.
Sci. U. S. A.</source>
<year>2011</year>, <volume>108</volume>, <fpage>16944</fpage>&#x02013;<lpage>16949</lpage><pub-id pub-id-type="doi">10.1073/pnas.1111558108</pub-id>.<pub-id pub-id-type="pmid">21963983</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="book" id="cit17"><person-group person-group-type="allauthors"><name><surname>Lawrence</surname><given-names>B. M.</given-names></name></person-group> In <source>Mint: The genus
Mentha</source>; <person-group person-group-type="editor"><name><surname>Hardman</surname><given-names>R.</given-names></name></person-group>,
Ed.; <publisher-name>CRC Press</publisher-name>: <publisher-loc>Boca
Raton, FL, USA</publisher-loc>, <year>2007</year>; pp <fpage>1</fpage>&#x02013;<lpage>547</lpage>.</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Chemler</surname><given-names>J. A.</given-names></name>; <name><surname>Koffas</surname><given-names>M. A.</given-names></name>
<source>Curr. Opin. Biotechnol.</source>
<year>2008</year>, <volume>19</volume>, <fpage>597</fpage>&#x02013;<lpage>605</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2008.10.011</pub-id>.<pub-id pub-id-type="pmid">18992815</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Mitchell</surname><given-names>W.</given-names></name>
<source>Curr. Opin. Chem.
Biol.</source>
<year>2011</year>, <volume>15</volume>, <fpage>505</fpage>&#x02013;<lpage>515</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2011.05.017</pub-id>.<pub-id pub-id-type="pmid">21684801</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Ajikumar</surname><given-names>P. K.</given-names></name>; <name><surname>Xiao</surname><given-names>W. H.</given-names></name>; <name><surname>Tyo</surname><given-names>K. E. J.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Simeon</surname><given-names>F.</given-names></name>; <name><surname>Leonard</surname><given-names>E.</given-names></name>; <name><surname>Mucha</surname><given-names>O.</given-names></name>; <name><surname>Phon</surname><given-names>T. H.</given-names></name>; <name><surname>Pfeifer</surname><given-names>B.</given-names></name>; <name><surname>Stephanopoulos</surname><given-names>G.</given-names></name>
<source>Science</source>
<year>2010</year>, <volume>330</volume>, <fpage>70</fpage>&#x02013;<lpage>74</lpage><pub-id pub-id-type="doi">10.1126/science.1191652</pub-id>.<pub-id pub-id-type="pmid">20929806</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Friedman</surname><given-names>D. C.</given-names></name>; <name><surname>Ellington</surname><given-names>A. D.</given-names></name>
<source>ACS Synth. Biol.</source>
<year>2015</year>, <volume>4</volume>, <fpage>1053</fpage>&#x02013;<lpage>1055</lpage><pub-id pub-id-type="doi">10.1021/acssynbio.5b00190</pub-id>.<pub-id pub-id-type="pmid">26471233</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Winter</surname><given-names>J. M.</given-names></name>; <name><surname>Tang</surname><given-names>Y.</given-names></name>
<source>Curr.
Opin. Biotechnol.</source>
<year>2012</year>, <volume>23</volume>, <fpage>736</fpage>&#x02013;<lpage>743</lpage><pub-id pub-id-type="doi">10.1016/j.copbio.2011.12.016</pub-id>.<pub-id pub-id-type="pmid">22221832</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Toogood</surname><given-names>H. S.</given-names></name>; <name><surname>Cheallaigh</surname><given-names>A. N.</given-names></name>; <name><surname>Tait</surname><given-names>S.</given-names></name>; <name><surname>Mansell</surname><given-names>D. J.</given-names></name>; <name><surname>Jervis</surname><given-names>A.</given-names></name>; <name><surname>Lygidakis</surname><given-names>A.</given-names></name>; <name><surname>Humphreys</surname><given-names>L.</given-names></name>; <name><surname>Takano</surname><given-names>E.</given-names></name>; <name><surname>Gardiner</surname><given-names>J. M.</given-names></name>; <name><surname>Scrutton</surname><given-names>N. S.</given-names></name>
<source>ACS Synth. Biol.</source>
<year>2015</year>, <volume>4</volume>, <fpage>1112</fpage>&#x02013;<lpage>1123</lpage><pub-id pub-id-type="doi">10.1021/acssynbio.5b00092</pub-id>.<pub-id pub-id-type="pmid">26017480</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Croteau</surname><given-names>R.</given-names></name>; <name><surname>Venkatachalam</surname><given-names>K. V.</given-names></name>
<source>Arch. Biochem.
Biophys.</source>
<year>1986</year>, <volume>249</volume>, <fpage>306</fpage>&#x02013;<lpage>315</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(86)90007-X</pub-id>.<pub-id pub-id-type="pmid">3755881</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Crowell</surname><given-names>P. L.</given-names></name>; <name><surname>Gould</surname><given-names>M. N.</given-names></name>
<source>Crit. Rev. Oncog.</source>
<year>1994</year>, <volume>5</volume>, <fpage>1</fpage>&#x02013;<lpage>22</lpage><pub-id pub-id-type="doi">10.1615/CritRevOncog.v5.i1.10</pub-id>.<pub-id pub-id-type="pmid">7948106</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Kjonaas</surname><given-names>R. B.</given-names></name>; <name><surname>Venkatachalam</surname><given-names>K. V.</given-names></name>; <name><surname>Croteau</surname><given-names>R.</given-names></name>
<source>Arch. Biochem. Biophys.</source>
<year>1985</year>, <volume>238</volume>, <fpage>49</fpage>&#x02013;<lpage>60</lpage><pub-id pub-id-type="doi">10.1016/0003-9861(85)90139-0</pub-id>.<pub-id pub-id-type="pmid">3885858</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Lupien</surname><given-names>S.</given-names></name>; <name><surname>Karp</surname><given-names>F.</given-names></name>; <name><surname>Wildung</surname><given-names>M.</given-names></name>; <name><surname>Croteau</surname><given-names>R.</given-names></name>
<source>Arch. Biochem. Biophys.</source>
<year>1999</year>, <volume>368</volume>, <fpage>181</fpage>&#x02013;<lpage>192</lpage><pub-id pub-id-type="doi">10.1006/abbi.1999.1298</pub-id>.<pub-id pub-id-type="pmid">10415126</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Ringer</surname><given-names>K. L.</given-names></name>; <name><surname>Davis</surname><given-names>E. M.</given-names></name>; <name><surname>Croteau</surname><given-names>R.</given-names></name>
<source>Plant Physiol.</source>
<year>2005</year>, <volume>137</volume>, <fpage>863</fpage>&#x02013;<lpage>872</lpage><pub-id pub-id-type="doi">10.1104/pp.104.053298</pub-id>.<pub-id pub-id-type="pmid">15734920</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Ringer</surname><given-names>K. L.</given-names></name>; <name><surname>McConkey</surname><given-names>M. E.</given-names></name>; <name><surname>Davis</surname><given-names>E. M.</given-names></name>; <name><surname>Rushing</surname><given-names>G. W.</given-names></name>; <name><surname>Croteau</surname><given-names>R.</given-names></name>
<source>Arch. Biochem. Biophys.</source>
<year>2003</year>, <volume>418</volume>, <fpage>80</fpage>&#x02013;<lpage>92</lpage><pub-id pub-id-type="doi">10.1016/S0003-9861(03)00390-4</pub-id>.<pub-id pub-id-type="pmid">13679086</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>W&#x000fc;st</surname><given-names>M.</given-names></name>; <name><surname>Little</surname><given-names>D. B.</given-names></name>; <name><surname>Schalk</surname><given-names>M.</given-names></name>; <name><surname>Croteau</surname><given-names>R.</given-names></name>
<source>Arch. Biochem. Biophys.</source>
<year>2001</year>, <volume>387</volume>, <fpage>125</fpage>&#x02013;<lpage>136</lpage><pub-id pub-id-type="doi">10.1006/abbi.2000.2248</pub-id>.<pub-id pub-id-type="pmid">11368174</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Duetz</surname><given-names>W. A.</given-names></name>; <name><surname>Bouwmeester</surname><given-names>H.</given-names></name>; <name><surname>Beilen</surname><given-names>J. B. v.</given-names></name>; <name><surname>Witholt</surname><given-names>B.</given-names></name>
<source>Appl. Microbiol. Biotechnol.</source>
<year>2003</year>, <volume>61</volume>, <fpage>269</fpage>&#x02013;<lpage>277</lpage><pub-id pub-id-type="doi">10.1007/s00253-003-1221-y</pub-id>.<pub-id pub-id-type="pmid">12743755</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Vining</surname><given-names>K. J.</given-names></name>; <name><surname>Johnson</surname><given-names>S. R.</given-names></name>; <name><surname>Ahkami</surname><given-names>A.</given-names></name>; <name><surname>Lange</surname><given-names>I.</given-names></name>; <name><surname>Parrish</surname><given-names>A. N.</given-names></name>; <name><surname>Trapp</surname><given-names>S. C.</given-names></name>; <name><surname>Vroteau</surname><given-names>R. B.</given-names></name>; <name><surname>Straub</surname><given-names>S. C. K.</given-names></name>; <name><surname>Pandelova</surname><given-names>I.</given-names></name>; <name><surname>Lange</surname><given-names>B. M.</given-names></name>
<source>Mol. Plant</source>
<year>2017</year>, <volume>10</volume>, <fpage>323</fpage>&#x02013;<lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.molp.2016.10.018</pub-id>.<pub-id pub-id-type="pmid">27867107</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Ha</surname><given-names>N.-C.</given-names></name>; <name><surname>Choi</surname><given-names>G.</given-names></name>; <name><surname>Choi</surname><given-names>K. Y.</given-names></name>; <name><surname>Oh</surname><given-names>B.-H.</given-names></name>
<source>Curr.
Opin. Struct. Biol.</source>
<year>2001</year>, <volume>11</volume>, <fpage>674</fpage>&#x02013;<lpage>678</lpage><pub-id pub-id-type="doi">10.1016/S0959-440X(01)00268-8</pub-id>.<pub-id pub-id-type="pmid">11751047</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Kim</surname><given-names>S. W.</given-names></name>; <name><surname>Cha</surname><given-names>S.-S.</given-names></name>; <name><surname>Cho</surname><given-names>H.-S.</given-names></name>; <name><surname>Kim</surname><given-names>J.-S.</given-names></name>; <name><surname>Ha</surname><given-names>N.-C.</given-names></name>; <name><surname>Cho</surname><given-names>M.-J.</given-names></name>; <name><surname>Joo</surname><given-names>S.</given-names></name>; <name><surname>Kim</surname><given-names>K. K.</given-names></name>; <name><surname>Choi</surname><given-names>K. Y.</given-names></name>; <name><surname>Oh</surname><given-names>B.-H.</given-names></name>
<source>Biochemistry</source>
<year>1997</year>, <volume>36</volume>, <fpage>14030</fpage>&#x02013;<lpage>14036</lpage><pub-id pub-id-type="doi">10.1021/bi971546+</pub-id>.<pub-id pub-id-type="pmid">9369474</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Swainston</surname><given-names>N.</given-names></name>; <name><surname>Currin</surname><given-names>A.</given-names></name>; <name><surname>Day</surname><given-names>P. J.</given-names></name>; <name><surname>Kell</surname><given-names>D. B.</given-names></name>
<source>Nucleic Acids Res.</source>
<year>2014</year>, <volume>42</volume>, <fpage>W395</fpage>&#x02013;<lpage>W400</lpage><pub-id pub-id-type="doi">10.1093/nar/gku336</pub-id>.<pub-id pub-id-type="pmid">24782527</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Swainston</surname><given-names>N.</given-names></name>; <name><surname>Currin</surname><given-names>A.</given-names></name>; <name><surname>Green</surname><given-names>L.</given-names></name>; <name><surname>Breitling</surname><given-names>R.</given-names></name>; <name><surname>Day</surname><given-names>P. J.</given-names></name>; <name><surname>Kell</surname><given-names>D. B.</given-names></name>
<source>PeerJ. Comput. Sci.</source>
<year>2017</year>, <volume>3</volume>, <fpage>e120</fpage><pub-id pub-id-type="doi">10.7717/peerj-cs.120</pub-id>.</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Currin</surname><given-names>A.</given-names></name>; <name><surname>Swainston</surname><given-names>N.</given-names></name>; <name><surname>Day</surname><given-names>P. J.</given-names></name>; <name><surname>Kell</surname><given-names>D. B.</given-names></name>
<source>Protein Eng., Des. Sel.</source>
<year>2014</year>, <volume>27</volume>, <fpage>273</fpage>&#x02013;<lpage>280</lpage><pub-id pub-id-type="doi">10.1093/protein/gzu029</pub-id>.<pub-id pub-id-type="pmid">25108914</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Currin</surname><given-names>A.</given-names></name>; <name><surname>Swainston</surname><given-names>N.</given-names></name>; <name><surname>Day</surname><given-names>P. J.</given-names></name>; <name><surname>Kell</surname><given-names>D. B.</given-names></name>
<source>Methods Mol. Biol. (N.
Y., NY, U. S.)</source>
<year>2017</year>, <volume>1472</volume>, <fpage>63</fpage>&#x02013;<lpage>78</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-6343-0_5</pub-id>.</mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Perrin</surname><given-names>S.</given-names></name>; <name><surname>Gilliland</surname><given-names>G.</given-names></name>
<source>Nucleic Acids Res.</source>
<year>1990</year>, <volume>18</volume>, <fpage>7433</fpage>&#x02013;<lpage>7438</lpage><pub-id pub-id-type="doi">10.1093/nar/18.24.7433</pub-id>.<pub-id pub-id-type="pmid">2259632</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Ke</surname><given-names>S. H.</given-names></name>; <name><surname>Madison</surname><given-names>E. L.</given-names></name>
<source>Nucleic Acids Res.</source>
<year>1997</year>, <volume>25</volume>, <fpage>3371</fpage>&#x02013;<lpage>3372</lpage><pub-id pub-id-type="doi">10.1093/nar/25.16.3371</pub-id>.<pub-id pub-id-type="pmid">9241254</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="undeclared" id="cit41"><person-group person-group-type="allauthors"><name><surname>N&#x000ed; Cheallaigh</surname><given-names>A.</given-names></name>; <name><surname>Mansell</surname><given-names>D.</given-names></name>; <name><surname>Toogood</surname><given-names>H.</given-names></name>; <name><surname>Tait</surname><given-names>S.</given-names></name>; <name><surname>Lygidakis</surname><given-names>A.</given-names></name>; <name><surname>Scrutton</surname><given-names>N.</given-names></name>; <name><surname>Gardiner</surname><given-names>J.</given-names></name></person-group><source>Submitted for publication</source>.</mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Pedrioli</surname><given-names>P. G. A.</given-names></name>; <name><surname>Eng</surname><given-names>J. K.</given-names></name>; <name><surname>Hubley</surname><given-names>R.</given-names></name>; <name><surname>Vogelzang</surname><given-names>M.</given-names></name>; <name><surname>Deutsch</surname><given-names>E. W.</given-names></name>; <name><surname>Raught</surname><given-names>B.</given-names></name>; <name><surname>Pratt</surname><given-names>B.</given-names></name>; <name><surname>Nilsson</surname><given-names>E.</given-names></name>; <name><surname>Angeletti</surname><given-names>R. H.</given-names></name>; <name><surname>Apweiler</surname><given-names>R.</given-names></name>; <name><surname>Cheung</surname><given-names>K.</given-names></name>; <name><surname>Costello</surname><given-names>C. E.</given-names></name>; <name><surname>Hermjakob</surname><given-names>H.</given-names></name>; <name><surname>Huang</surname><given-names>S.</given-names></name>; <name><surname>Julian</surname><given-names>R. K.</given-names></name>; <name><surname>Kapp</surname><given-names>E.</given-names></name>; <name><surname>McComb</surname><given-names>M. E.</given-names></name>; <name><surname>Oliver</surname><given-names>S. G.</given-names></name>; <name><surname>Omenn</surname><given-names>G.</given-names></name>; <name><surname>Paton</surname><given-names>N. W.</given-names></name>; <name><surname>Simpson</surname><given-names>R.</given-names></name>; <name><surname>Smith</surname><given-names>R.</given-names></name>; <name><surname>Taylor</surname><given-names>C. F.</given-names></name>; <name><surname>Zhu</surname><given-names>W.</given-names></name>; <name><surname>Aebersold</surname><given-names>R.</given-names></name>
<source>Nat. Biotechnol.</source>
<year>2004</year>, <volume>22</volume>, <fpage>1459</fpage>&#x02013;<lpage>1466</lpage><pub-id pub-id-type="doi">10.1038/nbt1031</pub-id>.<pub-id pub-id-type="pmid">15529173</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Chambers</surname><given-names>M. C.</given-names></name>; <name><surname>Maclean</surname><given-names>B.</given-names></name>; <name><surname>Burke</surname><given-names>R.</given-names></name>; <name><surname>Amodei</surname><given-names>D.</given-names></name>; <name><surname>Ruderman</surname><given-names>D. L.</given-names></name>; <name><surname>Neumann</surname><given-names>S.</given-names></name>; <name><surname>Gatto</surname><given-names>L.</given-names></name>; <name><surname>Fischer</surname><given-names>B.</given-names></name>; <name><surname>Pratt</surname><given-names>B.</given-names></name>; <name><surname>Egertson</surname><given-names>J.</given-names></name>; <name><surname>Hoff</surname><given-names>K.</given-names></name>; <name><surname>Kessner</surname><given-names>D.</given-names></name>; <name><surname>Tasman</surname><given-names>N.</given-names></name>; <name><surname>Shulman</surname><given-names>N.</given-names></name>; <name><surname>Frewen</surname><given-names>B.</given-names></name>; <name><surname>Baker</surname><given-names>T. A.</given-names></name>; <name><surname>Brusniak</surname><given-names>M.-Y.</given-names></name>; <name><surname>Paulse</surname><given-names>C.</given-names></name>; <name><surname>Creasy</surname><given-names>D.</given-names></name>; <name><surname>Flashner</surname><given-names>L.</given-names></name>; <name><surname>Kani</surname><given-names>K.</given-names></name>; <name><surname>Moulding</surname><given-names>C.</given-names></name>; <name><surname>Seymour</surname><given-names>S. L.</given-names></name>; <name><surname>Nuwaysir</surname><given-names>L. M.</given-names></name>; <name><surname>Lefebvre</surname><given-names>B.</given-names></name>; <name><surname>Kuhlmann</surname><given-names>F.</given-names></name>; <name><surname>Roark</surname><given-names>J.</given-names></name>; <name><surname>Rainer</surname><given-names>P.</given-names></name>; <name><surname>Detlev</surname><given-names>S.</given-names></name>; <name><surname>Hemenway</surname><given-names>T.</given-names></name>; <name><surname>Huhmer</surname><given-names>A.</given-names></name>; <name><surname>Langridge</surname><given-names>J.</given-names></name>; <name><surname>Connolly</surname><given-names>B.</given-names></name>; <name><surname>Chadick</surname><given-names>T.</given-names></name>; <name><surname>Holly</surname><given-names>K.</given-names></name>; <name><surname>Eckels</surname><given-names>J.</given-names></name>; <name><surname>Deutsch</surname><given-names>E. W.</given-names></name>; <name><surname>Moritz</surname><given-names>R. L.</given-names></name>; <name><surname>Katz</surname><given-names>J. E.</given-names></name>; <name><surname>Agus</surname><given-names>D. B.</given-names></name>; <name><surname>MacCoss</surname><given-names>M.</given-names></name>; <name><surname>Tabb</surname><given-names>D. L.</given-names></name>; <name><surname>Mallick</surname><given-names>P.</given-names></name>
<source>Nat. Biotechnol.</source>
<year>2012</year>, <volume>30</volume>, <fpage>918</fpage>&#x02013;<lpage>920</lpage><pub-id pub-id-type="doi">10.1038/nbt.2377</pub-id>.<pub-id pub-id-type="pmid">23051804</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Winter</surname><given-names>G.</given-names></name>; <name><surname>Lobley</surname><given-names>C. M.</given-names></name>; <name><surname>Prince</surname><given-names>S. M.</given-names></name>
<source>Acta Crystallogr.,
Sect. D: Biol. Crystallogr.</source>
<year>2013</year>, <volume>69</volume>, <fpage>1260</fpage>&#x02013;<lpage>73</lpage><pub-id pub-id-type="doi">10.1107/S0907444913015308</pub-id>.<pub-id pub-id-type="pmid">23793152</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>McCoy</surname><given-names>A. J.</given-names></name>; <name><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name>; <name><surname>Adams</surname><given-names>P. D.</given-names></name>; <name><surname>Winn</surname><given-names>M. D.</given-names></name>; <name><surname>Storoni</surname><given-names>L. C.</given-names></name>; <name><surname>Read</surname><given-names>R. J.</given-names></name>
<source>J. Appl. Crystallogr.</source>
<year>2007</year>, <volume>40</volume>, <fpage>658</fpage>&#x02013;<lpage>674</lpage><pub-id pub-id-type="doi">10.1107/S0021889807021206</pub-id>.<pub-id pub-id-type="pmid">19461840</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Adams</surname><given-names>P. D.</given-names></name>; <name><surname>Afonine</surname><given-names>P. V.</given-names></name>; <name><surname>Bunkoczi</surname><given-names>G.</given-names></name>; <name><surname>Chen</surname><given-names>V. B.</given-names></name>; <name><surname>Davis</surname><given-names>I. W.</given-names></name>; <name><surname>Echols</surname><given-names>N.</given-names></name>; <name><surname>Headd</surname><given-names>J. J.</given-names></name>; <name><surname>Hung</surname><given-names>L. W.</given-names></name>; <name><surname>Kapral</surname><given-names>G. J.</given-names></name>; <name><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name>; <name><surname>McCoy</surname><given-names>A. J.</given-names></name>; <name><surname>Moriarty</surname><given-names>N. W.</given-names></name>; <name><surname>Oeffner</surname><given-names>R.</given-names></name>; <name><surname>Read</surname><given-names>R. J.</given-names></name>; <name><surname>Richardson</surname><given-names>D. C.</given-names></name>; <name><surname>Richardson</surname><given-names>J. S.</given-names></name>; <name><surname>Terwilliger</surname><given-names>T. C.</given-names></name>; <name><surname>Zwart</surname><given-names>P. H.</given-names></name>
<source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<year>2010</year>, <volume>66</volume>, <fpage>213</fpage>&#x02013;<lpage>221</lpage><pub-id pub-id-type="doi">10.1107/S0907444909052925</pub-id>.<pub-id pub-id-type="pmid">20124702</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Emsley</surname><given-names>P.</given-names></name>; <name><surname>Lohkamp</surname><given-names>B.</given-names></name>; <name><surname>Scott</surname><given-names>W. G.</given-names></name>; <name><surname>Cowtan</surname><given-names>K.</given-names></name>
<source>Acta Crystallogr., Sect. D:
Biol. Crystallogr.</source>
<year>2010</year>, <volume>66</volume>, <fpage>486</fpage>&#x02013;<lpage>501</lpage><pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id>.<pub-id pub-id-type="pmid">20383002</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Afonine</surname><given-names>P. V.</given-names></name>; <name><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name>; <name><surname>Echols</surname><given-names>N.</given-names></name>; <name><surname>Headd</surname><given-names>J. J.</given-names></name>; <name><surname>Moriarty</surname><given-names>N. W.</given-names></name>; <name><surname>Mustyakimov</surname><given-names>M.</given-names></name>; <name><surname>Terwilliger</surname><given-names>T. C.</given-names></name>; <name><surname>Urzhumtsev</surname><given-names>A.</given-names></name>; <name><surname>Zwart</surname><given-names>P. H.</given-names></name>; <name><surname>Adams</surname><given-names>P. D.</given-names></name>
<source>Acta Crystallogr., Sect.
D: Biol. Crystallogr.</source>
<year>2012</year>, <volume>68</volume>, <fpage>352</fpage>&#x02013;<lpage>367</lpage><pub-id pub-id-type="doi">10.1107/S0907444912001308</pub-id>.<pub-id pub-id-type="pmid">22505256</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="computer-program" id="cit49"><person-group person-group-type="allauthors"><name><surname>Frisch</surname><given-names>M. J.</given-names></name>; <name><surname>Trucks</surname><given-names>G. W.</given-names></name>; <name><surname>Schlegel</surname><given-names>H. B.</given-names></name>; <name><surname>Scuseria</surname><given-names>G. E.</given-names></name>; <name><surname>Robb</surname><given-names>M. A.</given-names></name>; <name><surname>Cheeseman</surname><given-names>J. R.</given-names></name>; <name><surname>Scalmani</surname><given-names>G.</given-names></name>; <name><surname>Barone</surname><given-names>V.</given-names></name>; <name><surname>Petersson</surname><given-names>G. A.</given-names></name>; <name><surname>Nakatsuji</surname><given-names>H.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Caricato</surname><given-names>M.</given-names></name>; <name><surname>Marenich</surname><given-names>A.</given-names></name>; <name><surname>Bloino</surname><given-names>J.</given-names></name>; <name><surname>Janesko</surname><given-names>B. G.</given-names></name>; <name><surname>Gomperts</surname><given-names>R.</given-names></name>; <name><surname>Mennucci</surname><given-names>B.</given-names></name>; <name><surname>Hratchian</surname><given-names>H. P.</given-names></name>; <name><surname>Ortiz</surname><given-names>J. V.</given-names></name>; <name><surname>Izmaylov</surname><given-names>A. F.</given-names></name>; <name><surname>Sonnenberg</surname><given-names>J. L.</given-names></name>; <name><surname>Williams-Young</surname><given-names>D.</given-names></name>; <name><surname>Ding</surname><given-names>F.</given-names></name>; <name><surname>Lipparini</surname><given-names>F.</given-names></name>; <name><surname>Egidi</surname><given-names>F.</given-names></name>; <name><surname>Goings</surname><given-names>J.</given-names></name>; <name><surname>Peng</surname><given-names>B.</given-names></name>; <name><surname>Petrone</surname><given-names>A.</given-names></name>; <name><surname>Henderson</surname><given-names>T.</given-names></name>; <name><surname>Ranasinghe</surname><given-names>D.</given-names></name>; <name><surname>Zakrzewski</surname><given-names>V. G.</given-names></name>; <name><surname>Gao</surname><given-names>J.</given-names></name>; <name><surname>Rega</surname><given-names>N.</given-names></name>; <name><surname>Zheng</surname><given-names>G.</given-names></name>; <name><surname>Liang</surname><given-names>W.</given-names></name>; <name><surname>Hada</surname><given-names>M.</given-names></name>; <name><surname>Ehara</surname><given-names>M.</given-names></name>; <name><surname>Toyota</surname><given-names>K.</given-names></name>; <name><surname>Fukuda</surname><given-names>R.</given-names></name>; <name><surname>Hasegawa</surname><given-names>J.</given-names></name>; <name><surname>Ishida</surname><given-names>M.</given-names></name>; <name><surname>Nakajima</surname><given-names>T.</given-names></name>; <name><surname>Honda</surname><given-names>Y.</given-names></name>; <name><surname>Kitao</surname><given-names>O.</given-names></name>; <name><surname>Nakai</surname><given-names>H.</given-names></name>; <name><surname>Vreven</surname><given-names>T.</given-names></name>; <name><surname>Throssell</surname><given-names>K.</given-names></name>; <name><surname>Montgomery</surname><given-names>J. A.</given-names><suffix>Jr.</suffix></name>; <name><surname>Peralta</surname><given-names>J. E.</given-names></name>; <name><surname>Ogliaro</surname><given-names>F.</given-names></name>; <name><surname>Bearpark</surname><given-names>M.</given-names></name>; <name><surname>Heyd</surname><given-names>J.
J.</given-names></name>; <name><surname>Brothers</surname><given-names>E.</given-names></name>; <name><surname>Kudin</surname><given-names>K.
N.</given-names></name>; <name><surname>Staroverov</surname><given-names>V. N.</given-names></name>; <name><surname>Keith</surname><given-names>T.</given-names></name>; <name><surname>Kobayashi</surname><given-names>R.</given-names></name>; <name><surname>Normand</surname><given-names>J.</given-names></name>; <name><surname>Raghavachari</surname><given-names>K.</given-names></name>; <name><surname>Rendell</surname><given-names>A.</given-names></name>; <name><surname>Burant</surname><given-names>J. C.</given-names></name>; <name><surname>Lyengar</surname><given-names>S. S.</given-names></name>; <name><surname>Tomasi</surname><given-names>J.</given-names></name>; <name><surname>Cossi</surname><given-names>M.</given-names></name>; <name><surname>Millam</surname><given-names>J. M.</given-names></name>; <name><surname>Klene</surname><given-names>M.</given-names></name>; <name><surname>Adamo</surname><given-names>C.</given-names></name>; <name><surname>Cammi</surname><given-names>R.</given-names></name>; <name><surname>Ochterski</surname><given-names>J. W.</given-names></name>; <name><surname>Martin</surname><given-names>R. L.</given-names></name>; <name><surname>Morokuma</surname><given-names>K.</given-names></name>; <name><surname>Farkas</surname><given-names>O.</given-names></name>; <name><surname>Foresman</surname><given-names>J. B.</given-names></name>; <name><surname>Fox</surname><given-names>D. J.</given-names></name></person-group><source>Gaussian 09 D.01</source>; <publisher-name>Gaussian, Inc.</publisher-name>: <publisher-loc>Wallingford, CT</publisher-loc>, <year>2016</year>.</mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Becke</surname><given-names>A. D.</given-names></name>
<source>J. Chem. Phys.</source>
<year>1993</year>, <volume>98</volume>, <fpage>5648</fpage>&#x02013;<lpage>5652</lpage><pub-id pub-id-type="doi">10.1063/1.464913</pub-id>.</mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Grimme</surname><given-names>S.</given-names></name>; <name><surname>Antony</surname><given-names>J.</given-names></name>; <name><surname>Ehrlich</surname><given-names>S.</given-names></name>; <name><surname>Krieg</surname><given-names>H.</given-names></name>
<source>J.
Chem. Phys.</source>
<year>2010</year>, <volume>132</volume>, <fpage>154104</fpage><pub-id pub-id-type="doi">10.1063/1.3382344</pub-id>.<pub-id pub-id-type="pmid">20423165</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Oostenbrink</surname><given-names>C.</given-names></name>; <name><surname>Villa</surname><given-names>A.</given-names></name>; <name><surname>Mark</surname><given-names>A. E.</given-names></name>; <name><surname>Van Gunsteren</surname><given-names>W. F.</given-names></name>
<source>J. Comput. Chem.</source>
<year>2004</year>, <volume>25</volume>, <fpage>1656</fpage>&#x02013;<lpage>1676</lpage><pub-id pub-id-type="doi">10.1002/jcc.20090</pub-id>.<pub-id pub-id-type="pmid">15264259</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Van
Der Spoel</surname><given-names>D.</given-names></name>; <name><surname>Lindahl</surname><given-names>E.</given-names></name>; <name><surname>Hess</surname><given-names>B.</given-names></name>; <name><surname>Groenhof</surname><given-names>G.</given-names></name>; <name><surname>Mark</surname><given-names>A. E.</given-names></name>; <name><surname>Berendsen</surname><given-names>H. J. C.</given-names></name>
<source>J. Comput. Chem.</source>
<year>2005</year>, <volume>26</volume>, <fpage>1701</fpage>&#x02013;<lpage>1718</lpage><pub-id pub-id-type="doi">10.1002/jcc.20291</pub-id>.<pub-id pub-id-type="pmid">16211538</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Ha</surname><given-names>N. C.</given-names></name>; <name><surname>Choi</surname><given-names>G.</given-names></name>; <name><surname>Choi</surname><given-names>K. Y.</given-names></name>; <name><surname>Oh</surname><given-names>B. H.</given-names></name>
<source>Curr.
Opin. Struct. Biol.</source>
<year>2001</year>, <volume>11</volume>, <fpage>674</fpage>&#x02013;<lpage>678</lpage><pub-id pub-id-type="doi">10.1016/S0959-440X(01)00268-8</pub-id>.<pub-id pub-id-type="pmid">11751047</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Schwans</surname><given-names>J. P.</given-names></name>; <name><surname>Kraut</surname><given-names>D. A.</given-names></name>; <name><surname>Herschlag</surname><given-names>D.</given-names></name>
<source>Proc. Natl. Acad.
Sci. U. S. A.</source>
<year>2009</year>, <volume>106</volume>, <fpage>14271</fpage>&#x02013;<lpage>14275</lpage><pub-id pub-id-type="doi">10.1073/pnas.0901032106</pub-id>.<pub-id pub-id-type="pmid">19706511</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Mansell</surname><given-names>D. J.</given-names></name>; <name><surname>Toogood</surname><given-names>H. S.</given-names></name>; <name><surname>Waller</surname><given-names>J.</given-names></name>; <name><surname>Hughes</surname><given-names>J. M. X.</given-names></name>; <name><surname>Levy</surname><given-names>C. W.</given-names></name>; <name><surname>Gardiner</surname><given-names>J. M.</given-names></name>; <name><surname>Scrutton</surname><given-names>N. S.</given-names></name>
<source>ACS Catal.</source>
<year>2013</year>, <volume>3</volume>, <fpage>370</fpage>&#x02013;<lpage>379</lpage><pub-id pub-id-type="doi">10.1021/cs300709m</pub-id>.<pub-id pub-id-type="pmid">27547488</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Siedenburg</surname><given-names>G.</given-names></name>; <name><surname>Jendrossek</surname><given-names>D.</given-names></name>; <name><surname>Breuer</surname><given-names>M.</given-names></name>; <name><surname>Juhl</surname><given-names>B.</given-names></name>; <name><surname>Pleiss</surname><given-names>J.</given-names></name>; <name><surname>Seitz</surname><given-names>M.</given-names></name>; <name><surname>Klebensberger</surname><given-names>J.</given-names></name>; <name><surname>Hauer</surname><given-names>B.</given-names></name>
<source>Appl. Environ. Microbiol.</source>
<year>2012</year>, <volume>78</volume>, <fpage>1055</fpage>&#x02013;<lpage>1062</lpage><pub-id pub-id-type="doi">10.1128/AEM.07059-11</pub-id>.<pub-id pub-id-type="pmid">22156419</pub-id></mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name><surname>Lygidakis</surname><given-names>A.</given-names></name>; <name><surname>Karuppiah</surname><given-names>V.</given-names></name>; <name><surname>Hoeven</surname><given-names>R.</given-names></name>; <name><surname>N&#x000ed; Cheallaigh</surname><given-names>A.</given-names></name>; <name><surname>Leys</surname><given-names>D.</given-names></name>; <name><surname>Gardiner</surname><given-names>J. M.</given-names></name>; <name><surname>Toogood</surname><given-names>H. S.</given-names></name>; <name><surname>Scrutton</surname><given-names>N. S.</given-names></name>
<source>Angew. Chem.,
Int. Ed.</source>
<year>2016</year>, <volume>55</volume>, <fpage>9596</fpage>&#x02013;<lpage>9600</lpage><pub-id pub-id-type="doi">10.1002/anie.201603785</pub-id>.</mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name><surname>Salis</surname><given-names>H. M.</given-names></name>; <name><surname>Mirsky</surname><given-names>E. A.</given-names></name>; <name><surname>Voigt</surname><given-names>C. A.</given-names></name>
<source>Nat. Biotechnol.</source>
<year>2009</year>, <volume>27</volume>, <fpage>946</fpage>&#x02013;<lpage>950</lpage><pub-id pub-id-type="doi">10.1038/nbt.1568</pub-id>.<pub-id pub-id-type="pmid">19801975</pub-id></mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name><surname>Salis</surname><given-names>H. M.</given-names></name>
<source>Methods Enzymol.</source>
<year>2011</year>, <volume>498</volume>, <fpage>19</fpage>&#x02013;<lpage>42</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-385120-8.00002-4</pub-id>.<pub-id pub-id-type="pmid">21601672</pub-id></mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name><surname>Alonso-Gutierrez</surname><given-names>J.</given-names></name>; <name><surname>Chan</surname><given-names>R.</given-names></name>; <name><surname>Batth</surname><given-names>T. S.</given-names></name>; <name><surname>Adams</surname><given-names>P. D.</given-names></name>; <name><surname>Keasling</surname><given-names>J. D.</given-names></name>; <name><surname>Petzold</surname><given-names>C. J.</given-names></name>; <name><surname>Lee</surname><given-names>T. S.</given-names></name>
<source>Metab. Eng.</source>
<year>2013</year>, <volume>19</volume>, <fpage>33</fpage>&#x02013;<lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.ymben.2013.05.004</pub-id>.<pub-id pub-id-type="pmid">23727191</pub-id></mixed-citation></ref></ref-list></back></article>